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Abstract 
Whilst personalized medicine (where interventions are precisely tailored to a patient’s 
genotype and phenotype, as well as the nature and state of the disease) is regarded as an 
optimal form of treatment, the time and cost associated with it means it remains inaccessible 
to the greater public.  Stratified medicine offers an option with many of the benefits without 
the associated costs; rather than treatments being unique to an individual, patients are 
grouped (stratified) according to whether they respond to a given treatment, allowing the 
treatment to be selected from an appropriate panel, and avoiding the common “trial and 
error” approach of replacing a therapy only once it is demonstrated to be ineffective in the 
patient.  For stratification to be effective, it is necessary to develop tests that can rapidly 
assess whether a treatment will be effective.  Here we examine the use of dielectrophoresis to 
determine whether cancer drugs like Iressa, Cisplatin and MTX (metateroxide) are efficatious 
by treating cancer cell lines (one expressing EGFR, one not) with the drug Iressa, which 
indicates discernable difference.  We also examine the use in assessing the efficacy of 
combination therapies, including both chemotherapeutic and radiotherapeutic interventions. 
Results suggest that a DEP-based assay could potentially be used in a standard pathology 
laboratory setting, where biopsy cells can be screened at low cost and high speed, enabling 
the selection of an appropriate course of treatment from the outset, increasing patient survival 
rates whilst reducing time and cost for the health provider. K562 is suspension cell line, 
butHN5 and T47D cell lines are both adherent cells and need to be detached before any 
experiment. Prior to the investigation of cancer treatments, the effect of various detachment 
methods on these cell lines were studied to find out whether these methods could impact the 
electrophysiological properties of the cells. The results in investigation of detachment 
methods exhibit that unlike chemical substances, a harvesting method significantly alters the 
values of dielectric parameters.  
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Chapter 1    
Introduction 
The applications of dielectrophoresis(DEP) in biological relevant fields have been 
significantly developed over recent years. This technique has demonstrated an effective 
ability in obtaining the electrophysiological properties of the cells by analysing the motion of 
the particles when subjected to a non-uniform electric field (Pethig et al. 2004). The label free 
separation of cancer cells from blood (Becker et al. 1994; Becker et al. 1995; Gascoyne et al. 
1997b; Gascoyne et al. 2009) and dielectric characteristics of heterogeneous stem cell 
populations (Flanagan et al. 2008) are examples of DEP potential in cell properties’ 
characterisation. In 1994, Gascoyne et al. determined the effective membrane capacitances of 
murine erythroleukemia cells and counterpart cells that had undergone chemically induced 
differentiation (Gascoyne et al. 1994). 
Since 1994 when membrane capacitances were determined by Gascoyne et al, many studies 
have been run regarding the investigation of the pathological state of the non-cancerous and 
cancerous cells through dielectric properties of the cells (Gascoyne et al. 1994). However, 
none of the reports has proved a link between the pathological and dielectric properties of the 
stem cells. Analyses of cells dielectric properties could be taken into consideration for cancer 
detection (Gascoyne et al. 1994; Gascoyne et al. 1997). With respect to results of these 
studies, alternation in dielectric properties of the cells can lead to the detection of the 
chemotherapeutic drugs on the cells.  
Chemotherapeutic drugs are classified into many categories in terms of their functions and 
effects to the cancerous cells. In chemotherapy, some drugs are quite common in cancer 
treatment such as Erlotinib, Cetuximab, Carboplatin, Cisplatin and Gefinitib (Harari & Huang 
2001). Evaluation of the chemotherapeutic drugs’ effects on cancer cells has become vital for 
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the oncologists to reach the most suitable treatment plan for cancer patients. Personalized 
medicine is the identification and delivery of the optimum set of medical interventions for a 
patient, both in terms of the type of intervention used (pharmacological or otherwise) and the 
amount of each drug prescribed.  Most common embodiments of personalized medicine use 
genetic information about the patient or disease in order to optimize treatment on a patient-
by-patient basis (Lu et al. 2014). Whilst this clearly has advantages for the patient, the cost of 
screening each disease puts personalized medicine beyond the reach of most providers.  An 
alternative approach, which offers many of the advantages of personalized medicine but at 
significantly lower cost, is stratified medicine. In this approach, patients are grouped 
according to whether their condition is likely to respond to a particular treatment, so that 
interventions are not prescribed routinely.  Consequently, if a patient’s particular variant of 
the disease is not susceptible to those drugs, it is detected before the particular treatment is 
started, rather than after a prolonged but unsuccessful treatment, enabling a more appropriate 
regimen to be introduced earlier. Personalized medicine and stratified medicine are 
definitions interchangeably used, but in majority of cases, personalized medicine is 
considered to be more specific to each patient whereas stratified medicine is more an 
expression of prescribed medicine for a group of patients. (Lu et al. 2014; Miller et al. 2011).  
One of the chemotherapeutic drugs mechanisms is inhibition of epidermal growth factor 
receptor (EGFR) in the cells. EGFR inhibitor drugs directly blocks the signalling process of 
tyrosine kinase or indirectly affect the monoclonal antibodies, which results in blockage of 
cell proliferation. Mutation of EGFRs can induce an abnormal activation of receptors 
involved in cancer cell proliferation. Inhibition of EGFR occurs when tyrosine kinase 
inhibitors bind to the tyrosine kinase domain in receptors, which blocks the EGF receptors. 
There are many EGFR inhibitor drugs available in clinical applications including Iressa, 
Cetuximab and Erlotinib (Zimmermann et al. 2006). 
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Inhibition of the epidermal growth factor receptor (EGFR) is a fast-developing solution for 
clinical treatment of the head and neck and breast cancer. Iressa (Gefinitib) is one of the 
recommended drugs which inhibits the overexpression of EGF receptors (also known as up-
regulation) in the cancerous cell lines in order to deteriorate the growth of local tumours 
(Lynch et al. 2004). Some drugs have completely different mechanisms such as DHFR 
inhibitor (dihydrofolate reductase) and other types of protein synthesis inhibitor, leading to 
common consequences like apoptosis and necrosis of cells. 
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Main aims and objectives of project: 
Prior to investigation of chemotherapeutic drugs on cells, it is crucial to find out whether or 
not detachment methods could impact the biochemical mechanism of the cells. Therefore, 
T47D (breast carcinoma cells) and HN5 (head and neck cancer) cells were examined by 
seven different detachment methods including chemical reagents and scraping (harvesting) to 
detect their effect on electrophysiological properties of the cells. Chemical substances were 
also tested on K562 cells to determine their effects on suspension cells.  
In the second part, the main aim was to investigate whether DEP has potential for use in 
stratified medicine by rapid identifying drug effects. Therefore, HN5 treated cells were 
examined by DEP experiments to evaluate the impact of different drugs including Gefitinib, 
Cisplatin and MTX (methateroxide) on electrophysiological properties of cancer cells. These 
drugs were used alone and accompanied by another drug as well as irradiation. The 
experiments were analysed by DEP micro-well kit (developed in University of Surrey) 
immediately after the treatments up to 22 hours post-treatment incubation. T47D cells were 
also examined throughout the same procedure when treated with Iressa, irradiation and a 
combination of both. 
The final part of this research focused on comparison of Iressa (Gifinitib) impact on HN5 and 
T47D cell lines through statistical analysis of dielectric parameter values. The investigation 
of these treatments can be a primary step to introduce DEP as an asset in “personalized” and 
“stratified” medicine studies.  
Results suggest that a DEP-based assay could potentially be used in a standard pathology 
laboratory setting, where biopsy cells can be screened at low cost and high speed, enabling 
the selection of an appropriate course of treatment from the outset, increasing patient survival 
rates whilst reducing time and cost for the health provider. 
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Chapter 2:  Literature review 
2.1 Introduction to cells 
Animal cells 
Cells are the smallest functional and biological unit of a living organism system which are 
known as “building blocks of life” (Youngson 2006, Reece 2011). Animal and plant cells are 
subgroups of the eukaryotic cells family. In Greek, the word eukaryote means “true nut”, and 
in biology, these sorts of cells contain a nucleus within the membrane-bound structure, unlike 
the prokaryotic cells such as bacteria. The biological structure of eukaryotic cells may vary 
among plants and animal cells; however, plasma membrane, cytoplasm and nucleus are the 
main elements of all mammalian structure. Figure 2-1 is a typical structure of a mammalian 
eukaryotic cell (Youngson 2006, Reece 2011).  
 
 
Figure 2-1 The typical structure of eukaryotic cells (http://biology.tutorvista.com/cell.html) 
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The plasma membrane is a barrier which separates the interior from exterior of the cells and 
controls the movement of different substances or materials into or out of the cytoplasm. The 
lipid bilayer of the cell membrane mainly consists of lipid molecules, and is responsible for 
blocking the permeability of materials such as ions and proteins towards or from the 
cytoplasm. This layer permits some materials, including water, oxygen and carbon dioxide to 
flow in and out of the cells. On the other hand, ions and some other micro molecules are 
restricted from diffusing across the lipid bilayer, but ion channels are designated to let the 
ions in or out of the membrane. K+ (Potassium) and Cl- (calcium) are the most common ions 
flowing across these ion channels. 
The most important part of the cell structure is the nucleus which is present in both animal 
and plant cells and houses and protects some vital elements such as ribosomes, RNA and 
most importantly DNA. The nucleus manages most of the activities which occur within cells 
including DNA replication and RNA synthesis. Unlike the prokaryotes, where DNA 
transcription process occurs in cytoplasm, this process in Eukaryotes takes place inside the 
nucleus where DNA is transcribed to mRNA.   
The space between the plasma membrane and the nucleus is filled with a jelly like material 
known as cytoplasm which is mainly made up with the cystol and organelles such as 
endoplasmic reticulum, lysosomes and Golgi apparatus. Cytoplasm runs many vital functions 
for the cells such as storage of energy and keeping the shape and consistency of the 
cell.(Youngson 2006, Reece 2011) 
For cell culture, cells are categorized based on their morphology or their functional features. 
In terms of their morphological characteristics, there are three main types (Blerkom, Gregory 
2004): 
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1. Epithelial-like: These kind of cells are adherent to a substrate or surface of culture 
flasks, and appear flattened and polygonal in shape (figure 2-2). Along with other 
tissues like connective, muscle and neurones tissues, these cells are considered as 
basic types of animal tissues. These cells are found in cavities and surfaces of blood 
vessels around animal bodies. Epithelial tissues are divided into three types including 
squamous, columnar and cuboidal. Ephitelial tissues form the main glands of body are 
responsible for many vital functions such as secretion, protection and detection of 
sensation (Abedin, King 2010). 
 
2. Fibroblast-like: cells are most common kind of connective tissues in body and also 
adherent to the surface of culture flasks, but their shape is bipolar and elongated. 
These type of cells usually form swirls in heavy cultures.(figure 2-3). These type of 
cells produce an extracellular matrix called collagen which is responsible for healing 
the wounds (Blerkom, Gregory 2004, Proetzel, Pawlowski et al. 1995).   
 
3. Lymphoblast-like: These are type of white blood cells responsible for immunity 
system, and there are two main groups of them which are B lymphocytes and T 
lymphocytes. Unlike the cells mentioned above, these cells (figure 2-4) do not adhere 
normally to a substrate but they remain in suspension with a spherical shape (Abedin, 
King 2010). 
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Figure 2-2: A microscopic view of epithelial tissues              Figure2-3: A microscopic view of fibroblast tissues 
                                               
Figure 2-4: A microscopic view of lymphoblast tissues 
(Obtained from http://www.pathology-home.com/new/2008080501.asp April2015) 
 
Cells like epithelial and fibroblast cells are known as adherent cells. In the process of 
adhesion, an extracellular matrix is synthesized by the cells. This process is mainly caused by 
the proteins known as cell adhesion molecules or adhesins like selectins, integrins and 
cadherins.  
Cell adhesion process is crucial for the cells as it maintains the multicellular structure which 
results to induce the cell signal transduction and pathogenesis of infectious organisms 
(Abedin, King 2010). These kinds of cells are grown in in-vitro form until the existing 
nutrients in the culture medium depleted and the available surface of the culture flask is 
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covered by layers of the cells. These cells are then detached from the surface later through 
different cell detachment methods which will be covered in later chapter.  
Extracellular matrix (ECM) is defined as collection of extracellular molecules which support 
the constructor and functions of neighboring cells. The structure and lineage of the ECM vary 
in different forms of cells, although the features of cell adhesion are the same such as cell-to-
cell communication and proliferation (Blerkom, Gregory 2004, Eibl, Benoit 2004).  
Trypsinisation is one of the most common cell detachment method in which a proteolytic 
enzyme detaches the adherent cells from the surface through breaking down the proteins of 
cells ECM. The cells will then become suspended and emerge in rounded shape unlike their 
adherent form which are elongated (Huang et al. 2010). 
Suspension cells like K562 cells are erythroleukemia type of cells and were found in 
immortalised myelogenous leukemia cell lines. Cells were firstly derived from a 53 years old 
female patient suffering from blast crisis. In terms of their shape and form, these cells are 
rounded and non-adherent meaning they are suspended in culture medium for in-vitro studies. 
Comparing to other suspension cells, these cells appear to be less clumping mainly due to the 
downregulation of surface adhesion molecules. Whenever the level of cells vital component 
like proteins or RNA reduces, downregulation occurs as a reaction to any form of external 
change(Andersson et al. 1979, Klein et al. 1976).  
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2.2 Cancer 
Cancer is referred to as types of disease which involve uncontrolled and unregulated 
proliferation of cells. In cancer, the abnormal growth of the cells forms into excess tissue 
called tumour.  In malignant types of cancer tumours, the proliferation of the cells may result 
to metastasis, cancerous cells which spread to the neighbouring or far tissues through 
lymphatic system or bloodstream. Growth of malignant tumours happens quickly over a short 
period of time which leads to occupy the space and nutrients sources belong to normal cells. 
Thus, the malignant cells may lead to the death of normal cells by physical and biological 
damages. However, benign tumours are another sort of cancerous cells which don’t have a 
potential to induce metastases in other organs of the human body(Sherwood 2015; Vogelstein 
& Kinzler 2002).   
The causes of cancer are still unknown, but there are many factors which help increase the 
possibility of cancer occurrence in human body. Genetic DNA abnormalities, alcohol, 
smoking, obesity, exposure to sun or radiation, lack of physical activity and environmental 
pollutants are main factors in risk of cancers. Approximately 60-90% of human cancers, a 
chemical or radionuclide element causes DNA mutation (known as carcinogen) in cancerous 
cells. In oncogenes process, uncommonly activated genes transform the normal cells into 
cancerous ones (Vogelstein & Kinzler 2002). A schematic view of a cancer cell is illustrated 
in figure 2-5. 
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Figure 2-5: Schematic diagram of cancer cells initiated from oncogenes (obtained from 
http://www.sekmchd.org/cms April 2015) 
 
 
2.2.1 Head and neck cancer  
Head and neck cancer is defined as type of cancer in which squamous cells begin to 
proliferate mostly in cavities around head and neck such as mouth, nose and throat. These 
types of cancerous cells are refereed as squamous cell carcinomas of the head and neck 
(HNSCC). This type of cancer could also emerge in the salivary glands containing other type 
of cells. Head and neck cancer are mostly considered as aggressive type of cancer as it could 
strongly damage the function of vital organs within head area (Figure 2-6)   (Hakim, Billan et 
al. 2011, Sherwood 2015).  
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Figure 2-6: A schematic view of organs affected by HN cancer 
(http://www.chemotherapy.com/new_to_chemo/tumor_101/head_and_neck_cancer Jan 2016) 
 
There are many factors involved in proliferation of HN(head and neck) cancer cells such as 
smoking tobacco, ultra violet light exposure, alcohol consumption, some chemical 
compounds mostly found in component of painting materials, over exposure to 
electromagnetic fields and certain viruses like HPV (human papillomavirus). The patients 
that suffer from HN cancer are likely at risk of metastasis to other organs of the body like 
lung.  According to recent statistics, head and neck cancer, fatal ranking is 8th in the world 
and the second deadliest cancer after prostate among men. This type of cancer usually 
emerges in men age between 55 to 70 and the survival rate is about 40-50% (Ridge, John 
Andrew 2008; Wallace, Audrey 2011). Head and neck cancer tumours in North America and 
Europe are mostly type of oral and oropharynx, and nasopharyngeal in Mediterranean 
countries. Nasopharyngeal cancer is the most fatal cancer among men in Southeast china and 
Taiwan. The most common cancer among men in Southwest Asia especially in Pakistan, 
Bangladesh, India and Sri Lanka has been found to be oral cancer mainly caused to men by 
the habit of chewing a type of tobacco (Jemal, Ahmedin 2006).  
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2.3 Cancer treatment 
Fortunately, there is a high chance of cure for patients with cancer if diagnosed on early 
stage. There are many methods employed for cancer treatment such as chemotherapy, 
surgery, radiotherapy and photodynamic therapy.  
 
2.3.1 Chemotherapeutic drugs 
For head and neck cancer, FDA has approved many chemotherapeutic drugs which some of 
them are quite common like Erlotinib, Cetuximab, Carboplatin, Cisplatin and Gefinitib. Each 
of these drugs can be prescribed solely or combined with either another drug or radiotherapy. 
The main mechanism of these drugs varies, but there are some of them with relatively the 
same impact on cancer cells. Some of chemotherapeutic drugs like Gefitinib(Iressa or 
ZD1839) are known as EGFR(epidermal growth factor) inhibitor, DHFR inhibitor 
(dihydrofolate reductase) or any other type of protein synthesis inhibitor leading to common 
consequences like apoptosis of cells(Hakim et al. 2011; Zimmermann,et al. 2006). There are 
some drugs such as Cisplatin which directly targets the structure of DNA leading to blockage 
of cancer cell proliferation. Cisplatin disrupts the crosslinking process of DNA which results 
to apoptosis (cell suicide) of cancer cells (Pruefer et al. 2008, Stordal, Davey 2007).  
2.3.2 Role of EGF receptors in cancer 
Epidermal growth factor receptor (EGFR) has a significant role in proliferation of epithelial 
tumor cells. Epidermal growth factor receptor (EGFR; ErbB-1; HER1 in humans) is member 
of EGF factor family of receptor protein kinases which operates as a cell surface receptor for 
the cell membrane. Overexpression (also known as up-regulation) of EGFR leads to 
proliferation and mutation of cancerous cells such as lung, breast and head and neck cancer 
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(Baumann et al 2004). In approximately 30% of all epithelial cancers, mutations or over-
activation of the EGFR is implicated in progression of cancer.  
Stimulation of EGFR pathways leads to enhanced tumor cell motility, adhesion and 
metastasis (Brockmann et al. 2003). Its effective role in proliferation of cancerous cells 
makes EGF receptors an appropriate target in treatment of cancer through interrupting the 
signal transduction of cell membrane. High levels of EGFR over expression in tumor cells 
lead to poor diagnosis and also resistance to radio and chemo therapy of cancers especially in 
squamous-cell carcinoma of head and neck (SCCHN).  
Consequently, EGFR inhibition can significantly induce the deterioration and death of 
tumour cells in various cancers such as breast, lung and head and neck cancers (Zimmermann 
et al. 2006). 
2.3.3 EGFR Inhibitors 
There are two main methods allocated for inhibition of EGF receptors of cancerous cells 
which are irradiation and chemotherapeutic drugs. Monoclonal antibodies and tyrosine kinase 
inhibitors are the two developed approaches which directly link to the extracellular receptor 
domains and EGFR tyrosine kinase, which is on the cytoplasmic side of the receptor. 
Inhibition of EGFR by monoclonal antibodies enhances apoptosis and reduces the chance of 
angiogenesis and metastases. However, monoclonal antibodies appear to be less effective 
against altered forms of EGFR in some cases like VIII receptor in some glioblastomas. 
Combination of these agents with traditional methods, radiotherapy and chemotherapy, could 
bring advantages in the treatment of cancers. Table 2-1 contains examples of tyrosine kinase 
inhibitors (Herbst 2004). Figure 2-7 indicates the EGFR signal transmitting process which 
results in metastasis of tumour cells. 
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Table2-1: Examples of tyrosine kinase inhibitors   
 
Agent                                     Description 
 
Tyrosine kinase inhibitors 
   
ZD1839 ( Iressa)   
 
OSI-774 (Erlotinib) 
 
CI-1033  (Canertinib)                
 
 
Reversible inhibitor, EGFR specific  
Reversible inhibitor, EGFR specific 
Irreversible inhibitor, pan-erbB 
 
Source: (Herbst 2004). 
 
 
 
 
 
Figure 2-7 Schematic representation of EGFR signal transmitting which results to growth and metastasis of 
tumour cells. Binding of EGF ligans with extracellular domain activates the tyrosine kinase receptor which 
phosphorylates proteins in the signal transduction pathway inducing of cell upregulation, angiogenesis, and 
motility. 
(Clin Cancer Res 2000:6:323–325). 
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2.3.4 Gefinitib (Iressa) 
(Iressa) or ZD1839 is one of the most commonly used drugs for treatment of cancer such as 
breast, lung and head and neck. The main mechanism of Gefiniib in treatment of tumours is 
not yet confirmed, but this drug may damage local tumours through blocking the activity of 
EGFR which are identified as a key driver of tumour growth in various types of cancer. 
Gefinitib is categorized as a EGFR inhibitor which deactivates the tyrosine kinase receptors 
leading to blockage of intracellular phosphorylation with transmembrane cell surface 
receptors (Takimoto, Calvo 2008). 
Iressa in-activates the EGFR tyrosine kinase through binding to the adenosine triphosphate 
(ATP)-binding site of the enzyme which leads to inhibit the malignant cells.  The molecular 
structure of the Gefitinib is shown in figure 2-8. 
 
 
Figure 2-8: molecular structure of Gefinitib (European Journal of Medicinal Chemistry) 
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2.3.5 Radiotherapy 
 
Radiotherapy is also one of the most common methods in treatment of head and neck cancer 
mostly accompanied by chemotherapeutic drugs. Radiotherapy employs radiation to 
neutralize the cancerous cells mainly by damaging their DNA structure resulting in necrosis 
or apoptosis of the cells. The resistance of the cancer cells against irradiation is called radio-
sensitivity which varies among different types of cancers and depends on various factors. The 
majority of epithelial cancerous cells like head and neck have proved to be moderately 
radiosensitive and need to be irradiated with relatively high dosage(Camphausen, Lawrence 
2008).   
Clinical research indicated that fractionated irradiation could have an effective impact on 
local control of tumour cells which show an overexpression of EGF receptors particularly in 
HNSCC and cervix carcinoma. On the other hand, when radiotherapy comes into long 
treatment sessions, the local control of EGFR overexpressing tumours becomes poor (Pillai et 
al. 1998). The results of Akimoto et al reiterated the poor influence of irradiation in long 
process treatment as EGFR overexpressing tumours provide a recovery for clonogetic cells to 
resist against the irradiation. The results also clarified a relationship between level of 
radiosensititvty, oxygenation of tumour cells and overexpression of EGFR (Akimoto, Hunter 
et al. 1999).  
Use of EGFR inhibitors combined with irradiation can decrease the un-controlled 
proliferation of tumour cells expressing EGF receptors such as breast and head and neck 
cancers (figure2-9). In fact, this combination appeared as promising modality to optimize the 
effect of irradiation in molecular targeted therapy of carcinoma cancers (Bauman et al. 2004).  
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 Figure 2-9 Schematic view of cell survival and cell death cycle which illustrates the effect of combination of 
irradiation, chemotherapy and targeted agent such as Erlotinib and Gefitinib on EGFR signalling transmission 
of receptors. Gefitinib and Erlotinib bind to the intracellular ATP binding site of EGFR, whilst irradiation 
enhances the radiosensitivity of cells leading to unregulated EGFR signalling 
(http://www.jaypeejournals.com/eJournals/) 
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2.4 Personalised and stratified medicine: 
Personalized medicine (PM) is defined as the most suitable set of parameters planned for 
each patient to reach the optimum outcome for medical treatment. Parameters include 
medical prescriptions, practices and any form of items specifically considered for a specific 
patient case.  In this method, the biological information of the cancerous cells are analysed 
and set up the best tailored treatment package for the patient is determined (Lu et al. 2014). 
Peronalised medicine and stratified medicine are definitions interchangeably used, but in 
majority of cases, personalised medicine is considered to be more specific to each patient 
unlike stratified medicine which is more an expression of prescribed medicine for group of 
patients (Miller et al. 2011; Academy of Medical Sciences 2015 ). 
Genetic information has the major role in personalised medicine as DNA contains all specific 
information for each person. There are many known genetic techniques commonly used for 
personlaised medicine studies such as genome sequencing which can detect influences of 
drugs and diseases on DNA like mutation of cancerous cells. RNA sequencing is also another 
technique found to be more helpful for these studies due to its potential to spot a broader 
level of influence in response to the environment (Danzon P & Towse A 2002).  
In stratified medicine, a group of patients with a common response to a specific treatment or 
same level of risk of disease like cancer is selected for investigation (figure 2-10). There are 
many benefits in the study of stratified medicine for patients, health care providers and also 
industry with production of therapeutic drugs and techniques. In other words, this type of 
investigation helps patient to benefit from more efficient treatment, health care providers to 
save more costs and budget and finally industry to develop the level of efficiency in 
production of therapeutics and diagnostics (Academy of Medical Sciences 2015; Karczewski, 
K. 2014).  
 22 
 
 
Figure 2-10: A schematic view of stratified medicine division when a group of mix patients break down into a 
few sub groups based on patients’ response to a specific drug 
 
For instance, in figure 2-11, the understanding about the cause of NSCLC(non-small cells of 
lung cancer) has been developed throughout many years to help scientists produce more 
efficient drugs through discovery of different causes linked with structure of oncogenes ( 
genes involved in proliferation of cancer cells) (Gerber DE & Minna JD 2010). 
 Both stratified and personalaised medicine tend to first increase the level of efficacy of 
treatments and minimize their side effects. For example, Ziagen (abacavir, an HIV nucleoside 
reverse transcriptase inhibitor) has been used many years for HIV patients, but this drug is no 
longer prescribed for all patients due to some fatal hypersensitivity to Ziagen detected in 
particular group (around 2-9%) of individuals. Oncogenomics is a term used to define the 
role of genomics and personalized medicine in treatment of cancers. Oncogenomics is found 
to the most important branches of genomics due to its vital role in drug treatment (Academy 
of Medical Sciences 2015).   
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Figure 2-11: The molecular basis of NSCLC: developing understanding over time (The academy of medical 
science 2013) 
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2.5 DEP technology   
2.5.1 AC Electric Field 
All materials are made of charged entities. Electric fields apply forces on these charged 
particles, and as a result, two main dielectric mechanisms take place: the displacement or drift 
of bound and free charges. These effects could be specific to the molecules of  each material 
depending on its molecular structure and the characteristics of the applied frequency. E fields 
trigger continuous decrease in permittivity and increase in conductivity of a medium as a 
function of frequency. Charge displacement expressed as giving rise to polarisation of the 
particles, is the first and most common event that happens to the material under the influence 
of the electric field. Charge drift is another main effect of E field which induces rise to the 
ionic conductivity.(Kramer F., Schonhals A., Luck W 2002) 
As the electric field removal discontinues, relaxation occurs, and the material returns to its 
original state. Polarisation is not instantaneous; charges take a finite amount of time to 
accumulate. The time which charged particles take to re-establish is called relaxation time(τ). 
In an AC electronic field, polarisation of charged particles highly depends on the frequency. 
At lower frequency, the direction of electric field changes before polarization reaches the 
maximum potential unlike the higher frequency which gains the highest potential before the 
direction of electrical field changes.  
Another dominating factor which controls the polarization at low frequencies is conductivity 
which defines the redistribution of the free charge. 
In physics, permittivity is a measure to express the effects of an electric field on the dielectric 
properties of the medium which means the flux initiated per unit charge in the medium. 
Therefore, the relationship between the electrical field and the polarisation could be realized 
by the value of the permittivity of the medium. As higher permittivity exists in a medium, 
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higher electronic flux is produced due to polarisation effect. As the polarization is associated 
with the strength of the electronic field and polarization, the permittivity will decrease if 
polarization process misses its response. The dielectric equation is given by: (Morgan, Green 
2003)  
 
                                                                                                                  [eq.1] 
 
Where the dielectric constant is (K), permittivity at the medium is (ε) and permittivity of free 
space is (ε0). 
 
2.5.2 Dielectrophoretic (DEP) 
As the force initiated from a non-uniform electric field is applied on the dielectric particles, a 
phenomenon will happen called DEP(dieletrophroresis). Consequently, charged particles 
exhibit their dielectrophrotic reaction to the present force.  The subjected force affects the 
particle features including physical structure (shape, size), dielectical properties. This is one 
of the main characterisations of DEP which dominates it in cell separation through 
manipulating the dielectric particles with an exceptional selectivity. In addition, DEP offers 
an exceptional application in investigating of the cell dielectric properties in medical aspects. 
Herbert Pohl in the 1950s first presented the term of dielectrophroresis(DEP) implies from 
the Greek word Phroein. Pohl explained this phenomenon as “the motion of suspension 
particles relative to that of the solvent resulting from polarization forces produced by an 
inhomogeneous electric field.” (Morgan & Green 2003) 
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If the dielectric particle suspended in the medium gains more polarization compared to the 
suspending medium, the charge density at the internal face of the interface between the 
suspension medium and the particle becomes higher than the charge density charge at the 
external face. As a result, the net initiated dipole aligned with lines of the electric field would 
flex in parallel with the particle facing the surface. The process is illustrated in figure 2-12: 
 
 
Figure 2-12:       A Dielectric Particle Suspended in a Uniform Electric Field 
Charged particles are more polarised in (a) and less polarised in (b) than he suspension medium. In figure (a) 
he net dipole is aligned with the electrical field as the charge particle is more polarise than the surrounding 
medium. In contrast, the net dipole aligns counter to the electric field when particles are less polarised he the 
surrounding medium (figure (b). 
 
As soon as the charged particles becomes less polarised than the surrounding medium, the 
charge of external aspect of the interface is more than the charges density at the internal 
aspect of the interface located between the particle and the suspending medium. As a result, 
the net dipole will align outward the direction of the electric field, and the electrical field will 
be curved around the charge particle. If the charge densities of the inter and external sides of 
the interface become equal, the amount of polarisability of both surrounding medium and he 
particle will be also equal.  
Coulombs law defines the interaction happens between the charges upon each face of the 
induced dipole. 
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                                                                                                                [eq.2]  
 
Where an electric field E generated by a single point charge Q1 at a certain distance r 
generates a force on the second charge Q2, and   ε is the permittivity of the material 
surrounding the particles.(Griffiths 1998) 
Regarding to the Colombs law, at the stationary mode of the particles suspended in a 
conductive medium, the net force applied on the particle is equal to zero, because the 
Coulomb force conveyed upon the two poles of the induced dipole is equal and opposite. 
Once the particles are set under the presence of a non-uniform electronic field (figure2-13), 
the strength of the electronic field is associated with the number of electric fields per unit 
area.  
 
Figuere2-13 the schematic diagram of the electric field at uniform(a) and non- uniform(b)condition. (a) shows 
the hemogenity of the electric field where the lines are in parallel mode, and (b) represents the electric field 
which has converge lines. 
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Under the non-uniform electric field, on one dipole has a bigger strength of the electric field 
than the other side. As a result, an imbalance of the coulomb forces applied on the induced 
dipole generates a translational force which leads particle suspended in the conductive 
medium to tolerate lateral shift. Polarisibility of the particles is a main factor to determine the 
direction of the particle displacement within the surrounding medium.  
Two main terms are defined for the polarisibility of the particles suspended in conductive 
medium. Positive DEP represents the condition that the particle is more polarised than the 
surrounding medium which allows particle to move in the direction of high strength field regions. 
In Negative DEP status, the particle is less polarised than the surrounding medium which makes 
particle to be repelled from the high field strength fields. If neither of these phenomenon takes 
place, the particle has the same polarisibility as the surrounding medium. In that case, the particle 
remains in the stationary status at certain frequency called crossover frequency (FCROSS, FC, 
FX or FX0). Positive and negative DEP conditions are illustrated in figure 2-14. 
 
 
 
Figure 2-14: A Schematic Diagram of Positive and Negative DEP. 
When the particle is more polarised than the surrounding medium(a) and is less polarised than the surrounding 
medium 
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The DEP force for the theoretical model defined for the homogeneous sphere suspended in 
conductive medium is given by following equation: 
 
                                                                                 [eq.3] 
 
Where r is the radius of the particle, εm is the medium permittivity and Re [K(ω)] is the real part 
of the Clausius-Mossotti factor. The Clausius-Mossotti factor is defined by Equation 4: 
 
                                                  
 
                                                                                             [eq.4] 
Where εp* and εm* are the complex permittivity of the particle and medium,  is the 
conductivity,   is the angular frequency of the applied electric field and is the imaginary unit  
( the square root of -1) 
The homogenous spherical model defined for the suspended particle in conductive medium has a 
single dispersion created by the charges located at the interface between suspending medium and 
the particle. Figure 2-12 is a dielectric spectrum of a homogenous dielectric particle in 
surrounding medium. 
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Figure2-15 A dielectric spectrum of a homogenous dielectric particle in surrounding medium.  
   
2.5.3 DEP biological cell model 
As a biological cell consists of membrane and cytoplasm with separate polarisibilities, 
homogenous spherical model cannot be defined for biological cells. Thus, multi-shell model is 
suggested to construe the concept of dielectric spectroscopy of the biological cells, by dividing 
the model into concentric spheres with increasing radii (Huang et al. 2002). Single shell model 
was offered by Reynolds and Hough in 1957, and has been developed in 70s and 80s decades by 
major numbers of projects including protoplasts, mitochondria or living cells (Asami et al. 1984). 
Single shell model represents a mammalian cell divided into a homogenous core (cytoplasm) 
surrounded by a shell (plasma membrane) as illustrated in figure 2-16. 
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Figure 2-16 A schematic view of a single shell model defined for the mammalian cells, where the r2 is the radius 
of the exterior of the cell, ε1,σ1, ε2,σ2 and ε3,σ3 are the relative permittivity and conductivity (σ) of the cell 
structure. 
 
Single shell model has been used widely for various cell types over recent years; however, his 
model has its own limits including problems with sub-shells existing inside the nucleus of the 
cytoplasm. The more sub-shells exist in the model; the harder it is to analyse the biological cell 
properties. 
 Effective complex permittivity represents the properties of each individual spheres in a 
combination form. The concept is defined by replacing the concentric sphere from the model with 
a combined shell (equation 5) 
 
                                                  [eq.5] 
 
Where 1 and 2 refer to the core and the shell, and r1 and r2 represent the radius of the core and  
the centre of the sphere to the outside of the shell. 
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The permittivity and the thickness of the cell membrane are the elements which define the 
specific membrane capacitance (CEFF). CEFF is associated with the surface morphology of 
the membrane whereby any change in membrane’s surface result in a change in the CEFF 
value. An increase in CEFF value can be initiated by the high number of blebs, folds, ruffles 
and microvilli in the cell membrane (Labeed et al. 2003). CEFF equation is given by: 
 
                                                                                                   [eq.6] 
 
Low frequency dielectric dispersion (LFDD) and the high frequency dielectric dispersion 
(HFDD) are the factors used to define the two dielectric dispersions of the mammalian cells 
which LFDD refer to the charges accumulated at the interface between the membrane and the 
suspending medium and HFDD refer to the charges at the interface between the suspending 
medium and the cytoplasm.  (Interface between cytoplasm and media) 
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2.5.4 Application of DEP in Biomedicine 
The application of AC electric field for biological cells was introduced back in 1966 when 
Pohl discriminated healthy cells from dead ones by DEP. Application of DEP in cancer 
investigation was first examined in 1983 by Mischel et al. when the behaviour of the 
melanoma cells was observed through applying a non-uniform electric field on  melanoma 
cells.  
2.5.4.1 DEP in detection 
DEP has become more popular in recent years among researchers because of its potential in 
investigation of cancerous cells. Basically, the characterisations of the cells called dielectric 
property are affected by employing an AC electronic field. The discrimination of the healthy 
and pathological cells can be examined through their subsequent alteration in dielectric 
properties. Erythrocytes cells were first investigated back in 1997 (Gascoyne, Wang et al. 
1997) through the infection of the parasite P.falciparum which is the main cause of Malaria 
(Gascoyne et al. 1997). Effective membrane capacitance is another dielectric property of cells 
measured before and after the infection through employing ROT (electro rotation) technique. 
DEP frequency cross over method was applied in order to reach dielectric data with less time 
required. In this method, the cells properties behaved differently to the effect of frequency 
variation from positive to negative until the DEP force become zero. After applying DEP 
over a range of medium conductivities, the diagnosis of the healthy cells from infected ones 
could be derived by their response which for healthy tissues was linear and non-linear for 
infected ones. However, the radii of both type of the cells were observed larger as the 
medium conductivity was increased, these results were not considered as an osmotic reaction 
of the medium conductivity.    
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In 1990, DEP technique was employed in order to detect the transformation of malignant 
cancerous cells before and after chemically induced alteration. The examination of cells 
dielectric response was carried out by light absorbance method. Murine erythroleukemia cell 
line (DS-19) response differentiated when they chemically induced by 
hexamethylenebisacetamide (HMBA) treatment (Becker et al. 1994). Carcinoma cancer was 
also examined by AC electrokinetic method, but it could not significantly produce any tissue 
specific information (Becker et al. 1994b, Dielectric-spectroscopy of human erythrocytes-
investigations under the influence of nystatin. 1994, Cytoplasm Resistivity of Mammalian 
Atrial Myocardium Determined by Dielectrophoresis and Impedance Methods. 2012). 
However, this method has the potential to give some exceptional benefits compared to 
conventional method (Becker et al. 1994b) 
2.5.4.2 Prognosis 
Diagnosing in early stage of cancer is still a challenging issue among medicine experts. 
Although a few indicators offered for prognosis investigations such tissue histopathology and 
lymph node involvement, variation in treatments response exhibited a new demand for an 
advanced technique for cancer prognosis.  
2.5.4.3 Drug screening 
Another phenomenal application of AC electrokinetic is drug screening which allows the 
researchers to observe the outcomes of drug screening within the human body. Apoptosis 
detection is one of the most challenging issues in drug screening due to its ability to 
discriminate the cancerous cells. Apoptosis is a physiological process of cell leading to some 
cell hazard changes (morphology) and death. These changes could occur as blobbing, cell 
shrinkage, nuclear fragmentation, chromatin condensation, and chromosomal DNA 
fragmentation. The progression of cancerous cells is associated with the development of the 
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apoptosis among the healthy cells. In case of apoptosis, cell fragments called apoptotic bodies 
quickly remove contents of the cell which results in termination of cells.  
Detection of apoptosis and elucidation of the apoptosis process are the two main applications 
of DEP techniques. Many methods have been recently proposed such confocal microscopy, 
microtitre (Yang et al. 2010) and electrophoresis. Due to the issues caused by labelling and 
dye rendering, above methods are likely not suitable for apoptosis detection. Recently, some 
techniques are found more convenient than conventional methods due to their special liability 
in screening of chemotropic agents and also no demand of labelling. 
Following the first usage of AC electronkinetic fields in drug screening of cancerous cells 
which was carried out in 1983 (Mischel and colleagues), a novel method was introduced by 
Wang et al. (2004) to investigate the effects of chemically induced apoptosis on effective 
membrane capacitance and conductance. The experiments mainly focused on the change in 
membrane capacitance and conductivity up to 4 hours after the treatment with Genistein 
(Wang et al 2004). 
2.5.5 DEP electrodes 
There are many types of known DEP electrodes used in investigation of human cells 
electrophysiological properties such as needle, interdigitated, zipper and recent electrodes of 
DEPfff. Here, the most frequent ones are listed:   
2.5.5.1- Needle electrodes  
As it sounds, these electrodes consist of two needles separated by a specific distance about 
100µm and facing each other. These electrodes have been used in many studies related to 
cancer cells such as physiology of K562 cells carried out by Labeed et al. in 2003 (Labeed 
et al. 2003).   
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2.5.5.2 - Castellated and interdigitated electrodes 
 These type of DEP electrodes consist of two planer electrodes in the shape of a square wave, 
in distance of 100µm facing each other Figure 2-17. 
In various studies, these electrodes have been used like the study of human red cells by DEP 
(Huang et al. 1999). The interdigitated electrodes have a similar structure but with longer 
dents and less gap between the electrodes. These types of electrodes could distribute an 
effective dielectrophoretic force to enhance cell viability and separation efficiency (Chang et 
al. 2003). Figure 2 shows castellated electrodes used for yeast investigation at University of 
Surrey.  
 
 
Figure 2-17: Castellated electrodes with yeast cells experiencing positive DEP (taken 
at the University of Surrey). 
 
2.5.5.3. Zipper electrodes  
These electrodes are formed in a zipper pattern which consist of interlocking circular 
electrode pads as shown in figure 2-18. The main advantage of this design is to push particles 
orthogonally to the electrode edge and leading to collect particles in one spot on the middle of 
electrode surface unlike the interdigitated electrodes keeping particles in a band. The pattern 
of zipper electrode has been developed in University of Surrey by Hoetges et al. in 
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2003(Figure 2-19). This design helped increase the DEP surface to localize the DEP signals’ 
zones and obtain data easier to analyse more than castellated or interdigitated electrodes. 
These electrodes have been used in many biological studies including yeast cells, bacterial 
spores, latex beads (Hoettges et al 2003) and DNA (Wang et al 2004).  
 
 
Figure 2-18: Schematic of the zipper electrode geometry used; interlocking circles cause particles to be pushed 
into the centre of the electrode “pads” 
 
 
Figure 2-19: a) zipper electrode profile which the white band space between the electrodes connected to a 
signal generator, (b) picture of the electrode during a DEP experiment 
(from the University of Surrey). 
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5- Polynomial electrodes: The geometry of this electrodes derived from Laplace's equation. 
According to the formula 7, electrodes lie on a circle of radius  and electrode pairs are 
subject to v1 v2 potentials. Thus, the distribution of electric field is defined as: 
(7) 
The magnitude of E becomes zero at the center point resulting to null value of 
dielectrophoresis force. Therefore, particles will be less polarizable than surrounding space 
and undergo negative DEP force leading them towards the centre of the quadrupole structure. 
Figure 2-20 shows an electrode with polynomial geometry of n=2 which experience positive 
and negative DEP force. 
 
Figure 2-20 a) Positive dielectrophoretic collection of the yeast cells 4b) negative dielectrophoretic collection of 
the yeast cells (Institute of Molecular and Biomolecular Electronics, University of Wales) 
 
2.5.5.4- Electrodes using DEP-FFF(field flow fractionation) 
 The electrodes which employ the DEP-fff technique could separate particles and cells in a 
continues flow. In fact, this technique perform the separation of particles based on electric 
conductivity or dielectric permittivity of the particles regardless of variation in the size of 
them. Thus, this technique is considered to be an appropriate option for biological studies in 
which the variation in size of cells appear to be an obstacle. As shown in figure 2-21, DEP-fff 
provides a balance between the upward-pushing DEP force and the downward-pulling 
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sedimentation force within a microfluidic channel in a laminar fluid flow with electrodes at 
its bottom (Yang et al.2014). 
 
Figure 2-21: A schematic view of microfluidic channel with a laminar fluid flow. The forces acting on particles 
in a DEP-FFF channel with electrodes width, interelectrode gap and channel. (Yang et al.2014) 
DEP-fff technique is mainly used for fractionation of biological cells to detect the differences 
in viability, stage of differentiation or phase of cell cycle. There were many biological studies 
carried out through this technique such as separation of cancerous cells from non-cancerous, 
fractionation of different types of blood cells, difference in viability of the cells and many 
more (G.D. Gasperis et al. 1999; Y.L. Li 2007). 
Despite its potential applications, this technique does have a drawback just like other 
methods. For instance, the large dimensions of chambers make these electrodes unsuitable for 
micro- and nanoscale systems. In addition, electrodes are located on glass commonly which 
maybe an issue is some cases, but more flexible material like polymide could improve the 
system. ( J. Vykoukal et al.2008)   
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2.6 DEP-microwell System 
DEP 3-D electrode microwell system was developed by Hoettges et al at university of Surrey 
(Hoettges et al. 2010). As shown in figure (2-22), DEP microwell chip consists of layers of 
electrodes and insulators containing a vertical hole through the structure with a transparent 
base glued at the bottom of the hole to create a self-contained sample chamber. 
 
 
                                   Figure 2-22 Schematic diagram of a DEP microwell electrode structure         
 
Figure 2-23 Real view of DEP microwell chip 
 
In this method, a camera is located above the microwell chip to capture an aerial image 
generated by the beam of light passing through the electrode wells. During the stage of 
picturing, cell displacement can be also observed (figure2-13). Negative and positive DEP 
forms during the performance of the AC electric field are exhibited in figure 2-24. 
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Figure 2-24 Schematic diagram of the microwell electrode containing a cell suspension where (a) is before 
DEP, (b) during negative DEP and (c) during positive DEP 
Birds-eye view of a DEP-well (d) with negative DEP and (e) with positive DEP. Adapted from Hoettges et al. 
(2009). 
 
As shown in figure (2-24 c) particles will be attracted by the perimeter of the wall where 
regions of high electric field strength exist at positive DEP condition. The concentration of 
the cells at the wall therefore will become higher which leads to decrease in light intensity at 
this region; accordingly, the light at the centre of the well will become lower. At negative 
DEP the cells accumulated at the centre of the well which causes decrease in light intensity at 
the centre and rise in light intensity at the edge of the wall. Every 3-5 seconds the net change 
in the intensity of the light passing through the wells is recorded by the captured images from 
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the camera. Before applying the electric current, the light intensity is normalize with the data 
collected from the image captured at zero time. A pre-programmed Matlab(Maths Works) 
code(GUI) is used to run and analyse the experiment. After collecting the all data from the 
captured images, a counter plot will be generated for each DEP frequency against the well 
radius and time (figure 2-25).        
 
Figure 2-25 Contour Plot Indicating a Change in Light Intensity in the DEP-microwel 
The x-axis indicates the radius of the well, which 1represents the band around the centre of the well and 10 is 
the perimeter of the well. The y-axis illustrates the period of time in second. Red colour indicates an increase in 
light intensity whilst dark blue indicates a decrease in light intensity. 
 
 
The mean charge in light intensity is determined for each captured image at each time interval, 
and then a spectrum will be plotted as a function of the frequency (figure 2-26) 
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                                                  An Example of DEP Spectra 
 
Figure 2-26 Two DEP spectra are shown, one from analysis of untreated E-coli cells and one from E-coli cells 
treated with polymycin B. 
( Hoettges et al. 2008). 
 
 
 
The mean charge in the intensity light of each image captured during the time of applying 
current is given by a point at each frequency. The standard deviation of the averaged change 
in the light intensity is shown by the error bars for each of the points. Through anoher 
programmed-code, fit curve will be fitted to the data points in order to obtain the dielectric 
properties of the cell including conductivity of the membrane, permittivity of the membrane, 
conductivity of the cytoplasm and permittivity of the cytoplasm.(Duncan, Shelmerdine et al. 
2008). DEP microwell system has been employed in many studies in the past to correlate 
some biological phenomenon like apoptosis with dielectric properties of cells obtained by this 
system. In one of the most recent works conducted by Erin A Henslee et. al, DEP microwell 
system was used to sort the apoptotic from non-apoptotic cells based on changes in values of 
their dielectric properties. In another research done by Sue Chin et. al, cytoplasmic changes 
in dielectric properties of K562 cells were detected when exposed to apoptosis-inducing 
drugs either by joining a slow apoptotic cascade, or by near-immediate necrosis (Chin,S et al 
2006; Henslee et al. 2016).  
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Chapter 3: The effects of cell detachment methods on the 
dielectric properties of adherent cells 
3.1. Introduction 
Cell analysis techniques such as flow cytometry, whole-cell and automated patch-clamp, and 
dielectrophoresis require that cells be in monodisperse suspension in order for analysis to 
occur. Many of these cells are suspension cells, in that they naturally float in an aqueous 
environment and are therefore readily accessible for analysis.  However, many others – 
particularly those that form solid tissues – are adherent cells.  In vivo, these are found in 3D 
structures with other cells and extracellular matrices, and when grown in vitro will typically 
attach to the bottom of the culture vessel.  Where cells have a normally adherent phenotype, 
this requires that cells be removed from the surface of the culture flask or vessel (Keating et 
al. 2005).  This can be achieved in many ways, but most commonly either by the use of a 
dissociation medium of some form, or by scraping the cells from the surface.  Using practices 
from cell culture as a model, detachment is most commonly performed chemically, where 
chemical agents cause cellular release by chelating protein groups on the cell exterior.  If 
chemical detachment is to be avoided, the only alternative is to scrape the cells from the 
surface. 
Both methods have potential drawbacks; chemical methods may alter the properties of the 
cells to such a degree as to cast doubt on the validity of the measurement, whilst scraping 
may cause physical damage to the structure of the cells.  Where the analysis is targeted at the 
membrane properties, these could be compromised by surface modifications caused by the 
method of detachment.  Scraping, as stated above, has been shown to cause significant 
amounts of mechanical damage to the cell population; furthermore, Van Veldhoven et al found 
that the mechanical harvesting method imposes some stress on the cells and may disrupt the 
drift of the Ca 2+ ions (Van Veldhoven et al. 1988). However, whilst some investigations have 
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examined the effects of particular detachment methods (Van Veldhoven et al 1988; 
Kirkpatrick et al 1985), no comparative study has been undertaken to allow practitioners to 
fully account for the effects arising from a selected detachment method.   
The assessment of the effects of detachment methods on cells is further complicated by 
difficulties in providing a control in such measurements, since all cells to be measured have 
been detached and hence no such thing exists as a “healthy control” adherent population in 
suspension. To compensate for this, in this chapter I use dielectrophoresis (DEP) to assess the 
impact of different detachment methods on the electrophysiology of adherent cells, using two 
adherent cell lines detached by multiple methods, and comparing against a control cell line of 
suspension cell in both the native state and subject to the same chemical treatments.  DEP has 
increasingly been applied to studying the electrophysiological properties of cells; it has been 
shown to be an effective tool for obtaining electrophysiology parameters such as membrane 
resistance and capacitance, and cytoplasmic conductivity and permittivity, by analysing cell 
motion when subject to a non-uniform electric field (Pethig et al. 2004). It has been widely 
applied to a range of cell types, and has been sufficiently sensitive to discriminating between 
cancerous and normal cells (Voldman et al. 2006; Becker et al 1994); measure ionic 
composition of drug-resistant and drug-sensitive cancer cells as a possible basis for diagnosis 
(Vykoukal et al 2008); to distinguish between stem cells with different differentiation fates 
(Gascoyne et al 1994); and to study cellular processes such as apoptosis (Duncan et al 2008). 
In order to assess the effects of both chemical detachment and scraping, we have used DEP to 
analyse the dielectric properties of two adherent cell lines when treated with four different 
detachment reagents (Trypsin-EDTA, Dissociation Fluid, Dissociation Buffer and Accutase), 
as well as a reagent-free scraping method. Furthermore, we have also treated a suspension 
cell line with the same reagents in order to ascertain whether these cause any changes in the 
cell properties when compared to an untreated suspension cell population. 
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3.2. Methods 
3.2.1 Cell culture 
Two adherent cell lines, HN5 (Head and neck squamous cell carcinoma) and T47D (Breast 
epithelial carcinoma), and one suspension cell line K562 (myelgenous leukaemia) were used 
in this study. HN5 and K562 (gifted by Dr Helen Coley from department of Biochemistry 
University of Surrey) cells were cultured in modified RPMI-1640 medium supplemented 
with 10% heat activated foetal bovine serum (Biosera, Boussens) and 2mM stable L-
Glutamine (Biosera). For T47D cells, DMEM (Dulbecco’s modiﬁed Eagle's medium; 
Biosera) with stable L-Glutamine and FBS has been used. All the cells were seeded at 106 
cells/ml in a culturing flask, and every other day the culture medium was replenished with 
new medium in order to resupply the source of energies for adherent cells. The cells were 
grown in different size of culturing flasks including T25, T75, and T175 .In order to examine 
scraping as a detachment method, HN5 and T47D cells were also cultured in petri dishes in 
an incubator at 5% CO2 95% humidified air at 37
o C. Whenever the cells have reached the 
80% of confluence on the surface of the flask, they were passaged and seeded to new flasks. 
In the process of cell passaging, the cells were firstly washed with phosphate buffer saline 
(PBS, without Mg ad CA) (Biosera, UK), then detached trough adding trypsine_EDTA 
(Biosera) into culturing flask in usually four minutes incubation. After cells became detached 
from surface, culture medium was added to the flask in order to de-activate the harmful effect 
of trypsine on survival of the adherent cells. The mixture of Trypsine and culture medium 
then was centrifuged at 600 rpm for 6 minutes. Supernatant fluid was removed and then the 
cells were mixed with fresh growth medium heated at 37o in a water bath. At the final stage, 
cells were reseeded in new flasks with fresh culturing medium.   
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3.2.2 Detachment methods 
3.2.2.1. Scraping: Once confluence reached approximately, 90%, HN5 and T47D cells 
grown in petri dishes were washed by PBS several times, and were detached gently by using 
scrapers (Greiner Bio-One). The solutions containing the detached cells and PBS were 
centrifuged at 600rpmxg for 6min, the supernatant was removed, and the cells were prepared 
as outlined in section 2.4 below.  
3.2.2.2. Detachment solutions: Cells were detached from flask surfaces using the following 
reagents.  Trypsin-EDTA is one of the most common used reagents for adherent cells due to 
its appropriate commercial price and also its easy experimentation procedure. This fluid is 
provided in different concentration in market depending on the type of cell lines. In this test, 
1x concentration was used.  Sigma-Aldrich Dissociation fluid, unlike Trypsin, is non-
enzymatic. Due to its chemical feature (non-enzymatic), this fluid is suggested for most of the 
adherent sort of cell lines. Gibco® Cell Dissociation Buffer is also another fluid, mostly 
suggested for lightly adherent cells such as HeLa and NIH, but not suitable for detachment of 
strongly adherent cells. The final detachment fluid Accutase® was solution (Sigma-Aldrich) 
which is described as an appropriate reagent for adherent cells especially for endothelial and 
neurons cells.  
The cells firstly were washed in PBS after emptying the medium from the culture flask. The 
reagents were then based on manual recommendation added to the flask with below amounts: 
Trypsin-EDTA 1x (4ml), Dissociation fluid (5ml), Cell Dissociation Buffer (6ml) and 
Accutase (5ml). The cells were then incubated at different times (in line with company 
recommendations) to detach from the surface of the flask. The time of the incubation for each 
of the reagents were as follows: Trypsin-EDTA 1x (5min), Dissociation fluid (10min), Cell 
Dissociation Buffer (20min) and Accutase (10min).  
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3.2.3. Viability test  
The viability of the suspension cells, and cells detached by fluid solutions, was assessed using 
trypan blue solution. In this method, cell viability is measured by a dye (Trypan blue) through 
counting the dyed cells. The dyed cells represent the dead cells and uncoloured ones 
represent the cells with intact membrane considered to be live cells (Kim et al. 2007).    
However, cells detached by scraping were often found associated with debris which made the 
trypan test difficult to read; a Green-red assay kit test (Sigma-Aldrich) was used for these 
cells, but again an accurate measurement could not be obtained mainly because of the 
overlapped area which provided errors in discrimination of green and red regions. 
 
 
Figure 3-1. Micrographs showing typical cells. Cells detached bychemical methods were observed to form 
dispersed, rounded cells such as the trypsin-detached HN5 cells in (A). Scraping, by contrast, produced more 
irregularly shaped cells, and multiple raft-like monolayer cell clumps such as those seen in (B). Note the 
presence of small, dark dots on both images. Scale bars: 100 _m. 
 
3.2.4. DEP procedure 
Prior to measurement, suspended cells were washed twice in a low-conductivity medium 
(0.5% glucose, 8.5% sucrose solution supplemented with PBS to adjust the conductivity to 
10mSm-1) and finally suspended in 1mL of the medium at a concentration of 106 cells/ml. To 
ensure that the solution has reached the desired conductivity, during adding the PBS to fluid, 
the conductivity was verified the by Jenway 470 conductivity meter.  The first stage of DEP 
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cells preparation is the same as passaging process in which fluid consisted of trypsinsed cells 
and fresh growth medium was prepared. After the fluid was centrifuged at 600 rpm in 6mins, 
the supernatant was disposed, and the cells were resuspended in DEP conductivity medium. 
Meanwhile, the viability test was carried out by using trypen blue solution to examine the 
viability of the cells and also use the images of haemocytometer to run the cell radius 
measurement in future. The final solution was added to DEP chip (figure 3-2) by syringe and 
covered glass was then placed on top of the wells. 
 
Figure 3-2 Real view of the process which the cells were added to the chip  
The DEP experiment was started by locating the DEP chips in DEP reader kit to be 
examined. As the chip connected to the frequency supplier, Matlab starts capturing the 
images of the cells subjected to different frequencies of electric field in twenty different wells 
of the DEP chip. The whole process of DEP examination was carried out in less than 
2minutes. At the end, a spectrum was generated by Matlab which presented in values of light 
intensity versus frequency.   
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Figure 3-3 An example of captured images by Matlab in examination of HN5cells 
 
 
                              Figure 3-4   An spectrum achieved from DEP examination of cell detachment mehods 
 
Each trial was repeated at 15 times, and the properties were derived by modelling separate 
experiments to determine mean and standard deviations. Spectra were modelled using a 
“single shell model” program in Matlab (Tennant et al.1964), where fitting was used to 
maximise the correlation coefficient between data and model. Average radius data were 
acquired by analyzing 100 cells using ImageJ. 
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3.3. Results 
Observation of the cells microscopically showed the populations of cells detached by fluid 
methods had achieved a round shape, whereas those detached by scraping consisted of cell 
clusters surrounded by substantial quantities of debris. The trypan blue test for HN5 and 
T47D cells indicated 95%±2% and 88%±3% viability for all of the detachment fluids. 
Scraping the cells often resulted in clusters of cells which produced non-uniform and mingled 
shape for the cells placed on the haemocytometer. Following that reason, no results were 
taken for the viability of the scraped cells. However, the quantity of cell debris observed 
indicated that viability was low, which is consistent with studies of scraping which reported 
cell viability as low as 37% (Vanveldhoven et al. 1988).  
Immediately before each trial of the DEP experiment, the cell radius measurements were 
carried out simultaneously with the viability cells. The average cell radii for HN5 cells was 
5.5±0.3µm, for T47D 6.3±0.45 µm and 5±0.2 µm for K562 cells.  These were then used for 
modelling using the single-shell model. No difference was observed in the radii of cells 
measured using different detachment techniques, except scraping for which it was difficult to 
obtain a meaningful radius measurement; for modelling purposes, the aforementioned value 
was used.  
Following spectrum acquisition, spectra were fitted separately, and also averaged and then 
fitted.  Figure 3-6 shows typical mean DEP spectra for HN5, T47D detachment methods and 
K562 cells treated with by two detachment chemicals, together with their best-fit lines.  
Notably, the spectra of T47D cell lines followed the example of the curves shown in Figure 
3-6a, where a “double-hump” shape indicated the presence of two populations; a “cell-like” 
population plus a second, much smaller population (Tennant et al. 1964).  This was not 
present in the K562 spectra, which could be successfully fitted with single population spectra 
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without significant error. The values of cell properties obtained by best-fit modelling method 
are gathered into figure 3-5.  
 
 
Figure 3-5. Derived dielectric properties of the three cell lines after treatment with various cell detachment 
methods. 
Key: (A) Accutase (B) Dissociation Fluid (Sigma) (C) Gibco(D) Scraping (E) Trypsin (F)Untreated. 
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Figure 3-6a) spectra acquired from HN5 cells showing the profile of three detachment methods including 
Trypsin, Dissociation buffer(D B in the figure) and scraping (SCP). Only the methods with the most significant 
effect were fitted into this spectra mainly due to clearer demonstration of the differences among the methods 
The n value (number of the experiments) for each treatment is 40 in total (10 attempts in average for each DEP 
trial) 
 
Figure 3-6b) The spectra of two detachment methods (Trypsin and scraping) which had the maximum effect on 
T47D cells properties. Detached adherent cells showed a typical “double-hump” profileconsistent with a two-
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population mixture, as with T47D cells detached by two scraping (broken line) and trypsin (solid line) in this 
example. The n value (number of the experiments) for each treatment is 40 in total (10 attempts in average for 
each DEP trial) 
 
Figure 3-6c) The profile of K562 cells treated by two of the reagents including Trypsin and dissociation 
buffer(indicated as Dis in the figure)) fitted among the untreated cells(named healthy).  Conversely, suspension 
cells such as K562 (B) were bestfitted using a single-population model, as can be seen in spectrafor untreated 
cells (green) and those treated with trypsin (red) and dissociation medium (blue). 
 
Considering the primary cell populations first, the derived dielectrical properties of the cells 
(effective capacitance and conductance of the membrane; conductivity and permittivity of the 
intracellular space) were as shown in figure 3-5.  In order to gain a better understanding of 
inter-medium variation, the derived parameters were tested for statistical significance using 
an ANOVA test.  Statistical significance was assessed for all four parameters (membrane 
capacitance and conductance, cytoplasmic capacitance and conductance) between all of the 
separation methods for each of the cell lines, in order to determine whether the properties of 
those treated with any of the methods produced a markedly different result. The results are 
gathered into tables for each cell lines as shown in table 3-1. 
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Table 3-1. Results of statistical analysis of the parameters shown in Fig. 3, showing the p-values derived from 
an ANOVA test of combinations of all tests against each other, for statistically significant differences 
 
 
  
The left column represents cytoplasm differences (permittivity below the black diagonal, conductivity above). 
The right column shows membrane differences (conductance above the diagonal, capacitance below). Where 
statistical significance is demonstrated, the result is highlighted in gray. Key: (A) Accutase (B) Dissociation 
Fluid (Sigma) (C) Gibco (D) Scraping (E) Trypsin (F) Untreated.  The black star represents the level of 
significance (*p<0.05, **p<0.01 and **p<0.001)  
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3.4. Discussion 
Notably, there was no difference between any K562 cells treated with any of the detachment 
solutions or the untreated controls, indicating that none of the solutions changed the 
properties of cells by alteration of membrane chemistry.  In analysis of adherent cell lines, 
two detachment methods generated significantly different results, scraping and Gibco 
substance.  There was a distinctive change in values of HN5 cells membrane capacitance and 
conductance when detached with scraping method. The value of conductance remarkably 
dropped from 190 to 55 s/m2 and capacitance from 16 to 8 mF/m2. The same decrease in 
value of conductance and capacitance was detected in T47D cells where conductance reduced 
from 350 to 45 55 s/m2 and capacitance from87 to 8.5 mF/m2. These values illustrate that 
scraped cells are significantly damaged by their detachment. Gibco produced statistically 
different membrane properties from the other chemical detachment methods for HN5, whilst 
T47D cells detached using the Gibco medium showed some statistically different cytoplasmic 
properties compared to other chemical methods varying from dissociation fluid and trypsin 
on cytoplasmic conductivity and from Accutase and dissociation fluid on permittivity. 
As can be seen, the method which produced the greatest deviation from the others was 
scraping as it produced cells with a lower cytoplasmic conductivity in HN5 as well as 
significantly altered membrane characteristics in both populations.  
These parameters are largely indicative of quality rather than being absolute due to the 
variation in shape among the population, but scraped cells are remarkedly different to those 
released chemically.  Whilst this may indicate that the scraped cells better represent the 
native state, the abnormally low value of recorded capacitance, together with lowered 
cytoplasmic conductivity, indicate significant amounts of cell membrane damage. 
Regarding the chemical detachment methods, we first consider the control cells (K562) 
where chemical treatment by different agents produced DEP spectra bearing a very close 
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similarity to the untreated population.  This suggests that, for K562 cells at least, cells are 
dielectrically unaffected by any of the chemical agents used.  HN5 cells exhibited a range of 
cytoplasmic conductivities between 0.4 and 0.55 Sm-1, though the error margins of Sigma 
fluid and trypsin overlap; the Gibco result was slightly lower.  However, the differences in 
membrane properties were more marked, with Gibco-detached cells having a significantly 
lower conductance and higher capacitance than the other methods.  All methods bar scaping 
produced highly similar results (within error margins) for both membrane and cytoplasm 
properties for K562, and for the membranes of T47D cells.  However, there was much greater 
variation in the cytoplasmic properties of T47Ds across all detachment types, with Trypsin 
and Sigma displaying the lowest conductivities (approximately 0.5 Sm-1) compared to Gibco 
(0.6 Sm-1). None of the conductivities is indicative of cell death, but may reflect changed in 
the internal processes of the cell in response to the physical process of detachment.   
 
The second population observed in the DEP spectrum could not be observed microscopically 
with any reliability, but when modelled as having a diameter of 1µm was found to be fairly 
consistent, with membrane capacitance 9-11 mFm-2, cytoplasmic conductivity 0-1 – 0.2 Sm-1 
and membrane conductance 125-500 Sm-2.  These properties are consistent with what might 
be expected of apoptotic bodies, formed as cells undergo apoptosis.  It is notable that these 
were not observed in the suspension cells treated with detachment agents, indicating that if 
apoptosis is present then it is caused by the detachment process rather than inherent toxicity 
of the agents themselves.  Furthermore, there were significant differences in the number of 
secondary bodies observed in the two adherent lines.  Absolute numbers could not be 
determined as the DEP spectrum is dependent on the influence of the particles on light 
scattering within the well, which is more effected by smaller particles, but whilst the second 
population varied between 8% (Trypsin, Accutase, Sigma) and 15% (Gibco) for HN5 cells, 
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T47D were much more significantly affected with second population effects contributing to 
between 35% (Sigma) and 40% (others) of the total. This is also significant when considering 
the wider range of cytoplasm conductivities in chemically detached T47D cells, since 
apoptosis is associated with many cellular processes which alter the cytoplasmic conductivity 
by trafficking potassium ions and also cause reduction in size of the cell radii (Duncan et al. 
2008); however, Gibco-detached cells had a lower conductivity than those harvested using 
other detachment methods in HN5 populations, indicating that it may be difficult to 
generalize about the effects of different methods across all cell lines.   
Similar to any form of research conducted in labratory, there were some uncertainty, errors 
and some limitations in practice. Most of errors came from variation in cell radii measured 
values and non-rounded shape of the cells especially with adherent cells used in this project 
like T47D. However, cell radius measurements were carried out for each experiment for at 
least 5 times prior to any DEP analysis to reduce statistical errors. Random laboratory 
contaminations also caused some distinctive interruptions in our experiments’ plan and 
process.  
More accurate cell radii measurements can be conducted by digital devices, although a digital 
counter was used for a few times, but the device appeared to have many malfunctions. 
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3.5. Conclusion 
The analysis of detached adherent cells is a widespread activity, but prior to this study it has 
always been taken on faith that the cellular properties are unaffected by the detachment 
process used.  In this project we confirm that for the three cells examined, the detachment 
process does not significantly affect the membrane, though there may be indications that 
there are variations in the intracellular conductivity caused by the process. 
Arguably there is no such technique as a perfect detachment method, since any means of 
detaching adherent cells from their native state will by definition alter the cell phenotype.  
Our studies indicated that in the control (suspension) line no changes were found in the 
dielectric properties of cells treated with detachment chemicals when compared to untreated 
suspension cells, indicating that these chemicals do not intrinsically affect the properties of 
cells.  However, when chemical methods are used to detach cells, there was evidence of 
apoptosis, with small particles (most likely apoptotic bodies) appearing in the DEP spectra.  
This was most significant with T47D where up to 40% of the spectrum was composed of 
potential apoptotic bodies.  The performance of the various fluid solutions was broadly 
comparable, though the Gibco solution appeared to produce results which differed from those 
generated by the other methods, and also exhibited the largest proportion of small bodies in 
the two adherent cell types, possibly in line with manufacturer’s advice that it is most 
effective for cells with a weak adherence to the surface.  However, all chemical methods gave 
substantially better results than scraping; although this method does not chemically alter the 
properties of the cells, the damage incurred by scraping produces significant changes in cells 
membrane properties that do not match the profile of cells detached by other methods, 
suggesting that it is an inappropriate method for detaching cells for monodisperse analyses.  
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Chapter 4: DEP in evaluation of cancer treatments  
 
4.1: HN5 cells treatment  
4.1.1. Introduction: 
One of the aims of medicine at present is to develop tools to identify the optimum drug 
combination to provide the maximum therapeutic benefit.  The idea of “personalised 
medicine”, where the dosages of many drugs are optimised specifically to the disease and 
physiology of each patient, is currently attracting significant attention but is complex and 
costly, since the methods for identifying the “best” combination of therapies has yet to be 
determined.  A more likely candidate for identifying therapies in the general population is the 
use of “stratified medicine” – that is, the selection of treatment regimens on the basis of 
whether the treatment will have an effect, or not.  The majority of the population will either 
respond to a given treatment, or will not, according to the biochemistry of the rogue cells; 
stratified medicine involves identifying the treatments which are most likely to be effective 
prior to treatment. 
Currently, there are other methods like flow cytometry and western blotting usd in analysis of 
chemotherapeutic drugs. In flow cytometry, particles in fuid are examined when pass through 
at specific spectrum of laser. The components of cell ls are labelled fluorescently and then 
excited by beam of laser to emit light at specific wavelengths. This method requires longer 
times and more cost compared to DEP. In  a contarary, DEP employs only short amount of 
time for prepration, DEP chip and the microwell kit (Gimsa et al 1994). 
One non-genetic marker of cell state is the electrophys-iological proﬁle, or electrome. Whilst 
conventional methodsof cell electrophysiological analysis such as patch-clamp and ﬂow 
cytometry are expensive and time-consuming, dielec-trophoresis (DEP) has been shown to be 
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an effective methodof assessing cell population state after drug action. Di-electrophoresis 
exploits the frequency variant electrical prop-erties of cells and can be used for both assessing 
themean passive electrical properties of cellular component (the resistance and capacitance of 
membrane and cytoplasm) and as the basis for a separation metho . It has been shown to be 
effective for detecting changes in cells dueto a range of pharmaceutical interventions, 
includingion channel blockers, apoptosis-inducing and lymphocyte-activating agents (Gimsa 
et al 1994; Pethig R 2017). 
Most common embodiments of personalized medicine use genetic information about the 
patient or disease in order to completely optimize treatment on a patient-by-patient basis (Lu  
et al. 2014). Whilst this clearly has advantages for the patient, the cost of screening each 
disease puts personalized medicine beyond the reach of most providers.  An alternative 
approach, which offers many of the advantages of personalized medicine but at significantly 
lower cost, is stratified medicine. In this approach, patients are grouped according to whether 
their condition is likely to respond to a particular treatment, so that interventions are not 
prescribed routinely.  Consequently, if a patient’s particular variant of the disease is not 
susceptible to those drugs, it is detected before thee particular treatment is started, rather than 
after a prolonged but unsuccessful treatment, enabling a more appropriate regimen to be 
introduced earlier. Personalized medicine and stratified medicine are definitions 
interchangeably used, but in majority of cases, personalized medicine is considered to be 
more specific to each patient whereas stratified is more expression of prescribed medicine for 
group of patients(Miller et al. 2011).  This allows patients to more efficient treatment, health 
care providers to save more costs and budget and finally industry to develop the level of 
efficiency in production of therapeutics and diagnostics(The Academy of Medical 
Sciencmedicine 2015) .  Both stratified and personalized medicine tend to first increase the 
level of efficacy of treatments and minimize their side effects. For example, Ziagen (abacavir, 
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an HIV nucleoside reverse transcriptase inhibitor) has been used for many years for HIV 
patients, but this drug is no longer prescribed for all patients due to some fatal 
hypersensitivity to Ziagen detected in particular group (around 2-9%) of individuals (Miller 
et al 2011). 
The aim of this chapter is to investigate the effects of different type of treatments on the 
electrophysiological properties of head and neck cancerous cells, to investigate the possibility 
of using DEP as a discriminator for stratified medicine by rapidly identifying a treatment 
response. HN5 cells are derived from head and neck carcinoma; as well as exhibiting 
constant rate of growth and high level of survival in cell culture, HN5 cells respond to a 
number of chemotherapy drugs. For this project, the response of HN5 cells was investigated 
with three agents that have completely different mechanisms of action on cancer cells.  These 
were Iressa (Giftinib or Zd1839), Cisplatin and metateroxide (MTX). Additionally, 
irradiation of the cells by radiotherapy was also another treatment included in the 
research(Harari & Huang 2004). Once all the treatments were investigated individually, some 
combinations of these treatments were carried out as the last part of this investigation, 
reflecting common combinational therapies currently in use. 
Gifitinib, also known as ZD1839 or by the tradename Iressa, is a commonly used 
chemotherapy drug used to treat many cancers, including those of the head and neck. This 
drug acts as an EGFR (epidermal growth factor receptor)  inhibitor, which deactivates the 
tyrosine kinase receptors on the cell surface.  This leads to the blockage of intracellular 
phosphorylation with transmembrane cell surface receptors (Takimoto et al 2008). HN5 cells 
have high level of EGFR expression scientifically known as over-expressed which make 
these cells a suitable target for this drug(Konecny, Pegram et al. 2006).  Cisplatin damages 
the cancerous cells through crosslinking of DNA which could result to apoptosis of the 
targeted cells. (Pruefer, Lizarraga et al. 2008; Stordal, Davey 2007). Cisplatin is mostly used 
 70 
 
in chemotherapy when used in combination with other chemotherapeutic drugs and 
irradiation. In this part, the effect of Cisplatin was researched to find out how resistant the 
HN5 cells would be when they are treated solely by cisplatin. MTX inhibits the synthesis of 
amino acid called Tetrahydrofolate which is one of the main element in the structure of DNA. 
In fact, it damages the structure of DNA like the function Cisplatin, but in a different way. 
(Rajagopalan, Zhang et al. 2002, Goodsell 1999). Radiotherapy is also known as one of the 
most effective treatment of cancers including head and neck. Irradiation could affect the 
integrity of cancer cells through inhibition or damaging of vital parts of DNA or vital proteins 
participated in important types of synthesis within the cytoplasm.  
4.1.2 Methods 
4.1.2.1. Cell culture 
HN5 (Head and neck squamous cells) were cultured in modified RPMI-1640 medium 
supplemented with 10% heat activated foetal bovine serum (FBS; Biosera) and 2mM stable 
L-Glutamine. The cells were seeded at scale of 106 cells/ml in culturing flask and in cell 
culture incubator at 5% CO2 95% humidified air at 37
o.  
4.1.2.2. DEP experiments 
 The cells were detached by the same procedure and substance (Trypsin-EDTA) and then 
transferred to the container for the rest of the experiment. Fluid containing the detached cells 
was centrifuged at 600 rpm in 6mins, the supernatant was disposed and the cells were 
suspended in DEP conductivity medium. Meanwhile, the viability test was carried out by 
using trypen blue solution in order to examine the viability of the cells and also use the 
images of hemocytometer to run the cell radius measurement in future. The trypan blue test 
for HN5 cells indicated a 95%±2% viability when detached by trypsin. Trypsin was selected 
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as the most suitable detachment fluid according to the investigation ran previously on 
different detachment methods. 
Cells were finally suspended in 1mL of the conductivity medium with mostly concentration 
of 107 cells/ml for DEP experiments. The final solution was finally added to DEP chip  by 
syringe and covered glass was then placed on top of the wells. The DEP experiment was 
started by locating the DEP chips in the DEP reader kit (developed at University of Surrey) to 
be examined. As the chip connected to the frequency supplier, Matlab starts capturing the 
images of the cells subjected to different frequencies of electric field in twenty different wells 
of the DEP chip. The whole process of DEP examination was carried out in less than 2 
minutes. At the end, a spectrum was generated by Matlab which presented in values of light 
intensity versus frequency. Each trial has been repeated for at least 15 times to reach more 
data for further analysis in Matlab. Each of the detachment trials has been repeated for more 
than 15 times.The spectra gained by the experiments were then imported to Matlab and 
modelled through the same method conducted for cell detachment methods. The most 
significant changes were observed at 6hr, 16hr and 22hr of the treatment trials and there were 
included in one single spectra(figure 1) to demonstrate the effect of Iressa on profile of HN5 
cells. 
4.1.2.3. Treatments  
Studies by Noro et al. (Noro et al 2006) against a panel of 15 cell lines with varying 
sucsceptibility to Iressa showed that sensitive cell lines had IC50 values in the 7-9 µM 
concentration range, whilst Knight et al. (Knight et al 2004)used a panel of different cancers 
and identified a median value of 3.98 µM, but that all sensitive cell lines except three outliers 
(uveal carcinoma, sweat gland sarcoma) showed IC50 values below 7.27 µM.  Consequently 
a final concentration of 8µM was selected. 
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Iressa known also as Gefitinib and ZD1839 was purchased (free base and in form of powder) 
from Stratech company. Iressa was then diluted in DMSO and then frozen for further studies. 
Once cells reached the level of confluency about 70%, Iressa (dissolved in DMSO) with 
concentration of 8µM was added to the culture flasks containing the cells and then left in 
incubator for post treatment trials in different times including right after adding the drug, 3Hr, 
6Hr, 12Hr, 16Hr, 20Hr and 22Hr to gain the progress of drug’s biological effect on the 
dielectric properties within the 22Hours after treatment of the cells. To ensure the cells were 
in healthy conditions, the untreated cells (HC) of the both cell lines was performed for each 
time of drug treatment trial.  
Vehicle control of DMSO with concentration of 0.05 and 0.1% was also conducted prior to 
each trial to indicate the response of untreated cells to this concentration of DMSO. The 
results showed average viability of 92.6 to 94.9±2%. 
Cisplatin: For Cisplatin treatment, the same cell culture methods and conditions were 
conducted. cisplatin concentration was determined by using the highest values of IC50 for 
cell lines sensitive to the drug in order to ensure that an effect would be observed if resistance 
were present.  For example, Wang et al. (Wang et al. 2013) studied multiple cell lines and 
obtained IC50 values between 17.7 – 86.6 µM, whilst Tardito et al. (Tardito et al. 2009) 
examined a panel of 22 lines and found IC50 values raging between 2 and greater than 50 
µM.  Following the principle outlined for Iressa, we selected a concentration such that any 
cells sensitive to treatment would see at least 50% efficacy and selected 100 µM. 
The trials were carried out at the same times as Iressa treatment. The cells were detached by 
the same reagent and prepared for DEP experiments through the same method. The data 
gained by the treatment of Cisplatin showed no remarkable change at none of the post-
treatment trials.  
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Metateroxide (MTX): The same treatment procedure was carried out with metateroxide 
but with concentration of 10 µM. Similar to cisplatin, DEP results indicated no substantial 
change during the 22 hours post-treatment of HN5 cells with MTX.   
Irradiation: HN5 cells were cultured in the same conditions as previous treatments and 
prepared for DEP experiments by the same method. The dosage of exposure (8Gy) was 
selected based on studies carried out with similar cells’ confluency and culture flask (Balaban 
et al. 1996, Kim JC 2005). The same dosage was also suggested by Dr Myriam Barry 
working as physicist at Royal Surrey County Hospital based on her PhD thesis.  
Due to some resource availability in Royal Surrey County Hospital, only a few trials were 
carried out. The cells were taken to Royal Surrey hospital to be irradiated by superficial x-ray 
machine with dosage of 8mGray with duration of 15min exposure session. The flasks 
containing the treated cells were then returned straight back to DEP lab for running the DEP 
experiments. The data obtained from trials were then analysed through the same Matlab code. 
this investigation did not show any significant change from the time of exposure up to 22 
hours post-treatment incubation time, although the dielectric values derived for the model are 
tabulated in table 4-b. 
Combined Irradiation/Iressa: With respect to the research conducted by Akimoto et 
al. in 1999, the cells such as HN5 could potentially resist against the irradiation due to some 
reasons like overexpression of EGFR. (Akimoto  et al. 1999). In 2004 Baumann suggested 
that combination of EGFR inhibitors like Iressa with irradiation could result to suppress the 
proliferation of cells with high level of EGFR expression. (Baumann, Krause et al. 2004).  
Therefore, in this part of this research, HN5 cells were treated both with Iressa and irradiation 
to investigate the effect of this combination on electrophysiological properties of the cells. 
The cells were grown in the labs similar to the conditions used in previous treatments. Iressa 
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with the same concentration and solvent was injected to the culture flasks The cells were then 
taken to hospital (Royal Surrey County) for irradiation sessions. The treated flasks were 
straight after taken back to the lab for viability test and DEP experiments. Unlike previous 
drug treatment study, the cells were not incubated for further post-treatment trials. The cells 
were detached by trypsin and prepared for DEP experiment like previous steps. Trials were 
conducted only in four separate sessions and before running any DEP experiment for treated 
cells, healthy control (HC) trial was carried out to ensure the desired level of cells’ viability 
cultured in the lab. The profile of treated cells was then generated in the same matlab code 
and imported into one spectra including HC and also the profile of cells treated only by 
irradiation for better comparison.  
Combined Iressa/Cisplatin: According to the study carried out by Hambeck et. al, pre-
treatment with Iressa increased the cytotoxicity associated with cisplatin, meaning that Iressa 
intensifies the effect of Cisplatin on the cells. It was also proven that dosage of Iressa can be 
reduced when accompanied by Csiplatin (Hembeck et al 2015). Cells were cultured in T175 
flasks just like the other steps and then treated by the drugs when cell population reached 
70%. Iressa with concentration of 4 µM was first injected to the flasks and then Cisplatin 
with 100 µM concentration. The cells were then incubated for the post-treatment trials from 
6hr up to 22hr like the previous steps. In order to compare the effect of combination with 
single use of each drugs, single treatment of Iressa with concentration of 4 µM was carried 
out. Similar to the previous steps, for each trial, healthy control of the cells was done to 
ensure cells were grown in stable healthy form. Throughout, control populations were also 
measured. Trials were repeated 15 times. 
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The spectra gained from the fit-model Matlab code were then imported into one figure among 
the average spectra of HC (untreated cells), half dose treatment of Iressa and the single 
treatment of cisplatin conducted in previous step.   
4.1.3. Results 
Prior to analysis of treatments, vehicle and healthy control (with untreated cells) data were 
produced in Matlab model to ensure the cells’ integrity remained intact in presence and 
absence of drug solvent (DMSO). The values are tabulated in table 4-a. 
Table 4-a Table of average dielectric properties of untreated cells in presence and absence(HC control) of 
DMSO  for both 
 HN5 HC (healthy 
control) 
T47D HC HN5 vehicle 
control 
T47D vehicle 
control 
Cytoplasm conductivity 
(S/m) 
0.5±0.04 
 
0.58±0.03 
 
0.42±0.03 
 
0.5±0.018 
 
Cytoplasm permittivity 
(S/m) 
45±5.5 60±6 46±5 58±5 
Membrane conductance 
(mF/ m2) 
N/A 375±20 N/A 372±18 
Membrane capacitance 
(mF/m2) 
16±1.5 7±0.8 15±1.7 6.8±0.8 
 
Table 4-b Table of average dielectric properties of HN5 and T47D cells after irradiated in RSC hospital. 
 HN5 T47D 
Exposure to Irradiation Control 6h 16h 22h Control 6h 16h 22h 
Cytoplasm conductivity 
(S/m) 
 
0.5±0.04 
 
0.55±0.03 
 
0.33±0.03 
 
0.24±0.03 
 
0.48±0.03 
 
0.5±0.025 
 
0.5±0.02 
 
0.5±0.025 
 
Cytoplasm permittivity  
(S/m) 
 
45±5.5 43±6 44±6 44.5±5 60±6 62±6 60±6 59±5.5 
Membrane capacitance 
(mF/m2) 
16±1.5 15±1.5 15±2 15±1.8 7±0.8 7±0.8 7±0.9 6.8±0.9 
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The acquired DEP spectra for HN5 cells (figure 4-1) formed by including the two-dominant 
population observed in cell radii measurement. The dielectric properties of the cells including 
conductivity and permittivity of cytoplasm plus the membrane capacitance of HN5 cells from 
each type of treatments were then gained through the single-shell model programmed in 
Matlab. It was found that in most cases, the spectra could be best fitted using two populations 
combined, with one comprising small particles believed to be either cell fragments or 
apoptotic bodies (Tardito et al. 2009).  This population was modelled together with a second 
population resembling particles with radii equal to the measured cell population.  It is 
suggested that this population of fragments may be due to the interaction with the drug, it is 
predominately due to methods of cell detachment.  The data were imported to Excel for 
statistical analysis by ANOVA.Figure 4-1 to 3 illustrates the alteration happened to the 
properties of the cells caused by different treatments at certain times.  
 
Figur4-1 spectra acquired from HN5 cells showing the profile of three main trials of the same treatments 
among the healthy control(HC) conducted for untreated cells. The n value (number of the experiments) for each 
treatment is 40 in total (10 attempts in average for each DEP trial) 
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Figure 4-2 spectra obtained from HN5 cells showing the profile of cells treated solely with irradiation and 
combined with Iressa among the healthy control(HC) conducted for untreated cells. The n value (number of the 
experiments) for each treatment is 40 in total (10 attempts in average for each DEP trial) 
 
Figure 4-3 spectra obtained from HN5 cells showing the profile of cells treated solely with Cisplatin(Cis), 
half dose Iressa(halfdosegif) and combined with Iressa (cis+gif) among the healthy control(HC) conducted for 
untreated cells. The n value (number of the experiments) for each treatment is 40 in total (10 attempts in 
average for each DEP trial) 
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4.1.4 Discussion  
In figure 4-1 to 3 the curve and humps appeared on the spectra of treated cells represent the 
presence of second population which tend to become more distinctive when trials approach 
22hr post-treatment of the cells. The HC spectra in all figures reaches plateau from frequency 
105 to 107Hz like spectra of cells treated with Cisplatin, MTX and single Irradiation. This 
consistency represents a very low percentage of second population unlike the other spectra 
like Iressa treatment. As discussed before in cell detachment chapter, the rise in second 
population may define the effect of the drugs which triggers apoptosis or necrosis of the cells 
resulting in reduction of cell radius. Debris and other microorganism can be considered as 
apoptotic bodies produced by drug treatment. In figure 4-4 the difference in rate of second 
population in drug treatment of Iressa and untreated cells can be seen. 
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Figure 4-4: Microscopic images taken from cell radius measurement carried out on hemocytometer. Black dots 
represent non-viable cells meaning malfunction or death of cells in viability test. 
 
As shown in figure 4-4, the population of black dots start increasing noticeably since the time 
cells were treated with Iressa. Apart from black dots, another population of cells with much 
less radii than the cells in HC (assumed to represent untreated cells) emerged on 
hemocytometers especially at 22hr of post treatment time. This shrinkage in size of the cells 
may occur as a result of cells apoptosis or necrosis. These cells with small radii are the 
second population taken into analysis of cells dielectric properties in Matlab code.   
 
 
 
 
HC 6hr 
16hr
r 
22hr 
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Table 4-1 Table of population percentage and the cells radii values of HN5 cells from the time of adding drug 
to 22hr incubation time. Irradiation trials with no incubation and Cisplatin treatment with 22hr incubation. HC 
control was performed in parallel with all trials. Here is the average of all HC obtained from treatment trials. 
Trials(incub
ation time) 
HC 
1st pop 
HC 
2nd pop 
6HR 
(Iressa) 
6HR 
2nd pop 
16HR(Iressa) 16HR 
2ndpop 
22HR 
(Iressa) 
22HR 
2ndpop 
Cell radius 5.50E-
06 
1.00E-06 5.30E-06 1.20E-06 4.90E-06 8.00E-
07 
4.50E-06 5.00E-07 
Cell 
population 
percentage % 
95±4 5±3 82±9 16±9 55±4 41±8 38±4 45±7 
 
Iressa+ 
IRRADIATION 
2nd 
pop 
Irradiation 2nd 
pop 
Cisplatin 
(1st pop) 
2nd pop Cis+Iressa 
1st pop 
2nd pop 
4.50E-06 0.5-6 5.20E-06 1.00E-
06 
5.30E-06 0.9E-06 4.20E-6 4.50E-06 
40±4 38±7 82±4 30±3 80±4 16±4 28±5 65±6 
 
 
From the table above it can be seen that the size of the cell radii started reducing from 16hr of 
the post treatment which could define the shrinkage of the cells most probably as results of 
apoptosis or necrosis of the cells. This significant change in size of the cells lead to leakage 
of the vital materials to the outside which causes malfunction and finally death of the cancer 
cells. The rate of the first population also start decreasing noticeably which explains the 
transition of healthy cells to the other population mostly representing dead cells. The rate of 
these two populations almost leveled when cells treated with combination of drugs and 
irradiation.    
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Figure 4-5a) the values of cytoplasm conductivity for all types of treatment 
 
Figure 4-5 shows a substantial drop in value of cytoplasm conductivity from 0.5S/m to 
0.2S/m for all treatment which Iressa (except half dose) was involved. When cells only 
treated with Iressa and half dosage of Iressa (HD) combined with cisplatin, trend line shows 
that conductivity started decreasing from 6hr incubation time of treatment. When Iressa was 
used with irradiation, this value dropped down to the point which iressa itself reached after 
22hr of treatment.  
 
Figure 4-5 b) cytoplasm relative permittivity values of cells 
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Unlike the change occurred in values of cytoplasm conductivity, permittivity of the cells 
cytoplasm started increasing from 45 up to 100 when Iressa was used in treatment. When 
irradiation was combined with Iressa, the value of conductivity rose up straight from 45 to 80 
showing a significant rise. Irradiation and Cisplatin also left a slight influence on permittivity 
of cytoplasm in much lower scale compared to other Iressa treatments. 
 
Figure 4-5 c) values of cells membrane capacitance 
 
The membrane capacitance values in figure 4c indicate a distinctive decrease from 6hr to 
22hr of Iressa post treatment. Iressa also suppressed the value of capacitance from 15 to 8 
mf/m2 when combined with irradiation pretty much similar to the combination of half dose 
Iressa with Cisplatin.  
Cell apoptosis is one of the most common consequences caused by chemotherapeutic drug 
resulting to self-destroying of cells. Wang et. al in 2002 and also Pethig et al. in 2007 
observed a substantial change in membrane capacitance when cells were gone apoptotic. 
Therefore, the reduction in value of HN5 cells membrane capacitance in this investigation 
could be also a result of apoptosis. 
 83 
 
Unlike the other two combined methods, HN5 cells appeared to stand against the treatment of 
cisplatin, irradiation and MTX (metateroxide). In fact, the single treatment of Cisplatin, MTX 
and radiation have the minimal effect on the electrophysiological properties of the cells 
comparing to the other methods of treatments. In the following part, T47D cells were treated 
with Iressa and irradiation to investigate the effects of different treatments on properties of 
another cell line.    
 4.2 T47D cells treatment 
4.2.1 introduction 
In this part of the research, the impact of three different treatments on electrophysiological 
properties of breast cancer cells were examined. T47D cell line extracted from breast 
epithelial carcinoma was suggested for this investigation. Cells were planned to be treated 
firstly by Iressa (Gifitiib) then irradiation and finally by combination of Iressa with 
irradiation. Iressa is known as a common chemotherapeutic drug used in cancer treatment 
which inhibits the EGFR in cancer cells. Radiotherapy is also one of the most common 
treatments for cancer, but it will be much more efficient when prescribed with some 
chemotherapeutic drugs like Iressa (Chen et al 2007). 
4.2.2 Methods 
Cell culture: T47D cells were cultured in DMEM (Dulbecco’s modiﬁed Eagle's medium; 
Biosera) with stable L-Glutamine and FBS has been used. All the cells were seeded at 106 
cells/ml in a culturing flask in an incubator at 5% CO2 95% humidified air at 37
o C.   
Treatments: Once cells reach the level of population about 70%, Iressa with same 
concentration as HN5 (8micromL) was added to the culture flasks containing the cells and 
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then left in the incubator for post treatment trials in different times including right after 
adding the drug, 3Hr, 6Hr, 12Hr, 16Hr, 20Hr and 22Hr.  
For irradiation treatment, the cells were treated with Iressa (same concentration as before) 
prior to the exposure and then taken to the Royal Surrey Hospital for irradiation sessions. The 
untreated cells were also exposed at the same session to investigate the effect of irradiation 
itself on the cells. 
Viability test: The viability of detached cells was assessed using trypan blue solution. Unlike 
HN5 cells, when T47D are detached, cells do not look individually separated (figure 4-6) 
under microscope which causes difficulties for viability test (trypen blue in this case) and also 
cell radius measurement in DEP experiment.  
 
Figure 4-6. Micrographs showing typical cells.HN5 Cells detached by trypsin on the right appear to be more 
rounded and separate unlike T47D cells on the left. 
 
DEP experiment: Cells detached by Trypsin was centrifuged at 600 rpm in 6mins, the 
supernatant was disposed and the cells were resuspended in DEP conductivity medium. 
Meanwhile, the viability test was carried out by using trypen blue solution in order to 
examine the viability of the cells and also use the images of haemocytometer to run the cell 
radius measurement in future. Two cells population were observed similar to HN5 cells, but 
the second population emerged with remarkably high percentage on hemocytometer unlike 
the second population observed from HN5 cells. Cells were finally suspended in 1mL of the 
conductivity medium with mostly concentration of 107 cells/ml for DEP experiments. The 
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cell radius measurement was also performed prior to the DEP experiment for further data 
analysis in Matlab.To ensure the cells were in healthy conditions, the untreated cells (HC) of 
the cells was carried out for each time of treatment trial. 
The data gained through the DEP experiments were then imported to Matlab code to generate 
the spectra (Figure 4-7) of all treatments. The data generated for trials from 6hr up to 22hr 
had no significant change comparing to HC of the cells, but the first change was detected at 
post-treatment experiments of 22hr. The single treatment of Irradiation also showed no 
substantial difference, but when combined with Iressa, a distinctive change occurred.  
 
4.2.3 Results 
The data obtained from different treatments were imported to matlab to generate the average 
spectra. From all treatments carried out for T47D cells, only two of the treatments including 
22hr of Iressa and combination of Iressa with irradiation appeared to have significant change 
compared to model of untreated cells (healthy points). For better presentation, only these two 
treatments plus healthy control of HN5 cells were shown in one single figure (figure 4-7).  
 86 
 
 
Figure 4-7 spectra acquired from T47D cells showing the profile of two treatments with the most significant 
changes. Black line represents the trial of 22hr post-treatment (22hr) and doted blue line belongs to 
combination treatment of Iressa and Irradiation. The n value (number of the experiments) for each treatment is 
40 in total (10 attempts in average for each DEP trial) 
 
In contrast with the average spectra generated for HN5 cells, HC (untreated cells) seems to 
have more curves on the graph representing the high percentage of second population as 
observed in cell radii measurements of T47D cells. First half of the spectra (103-108) reflects 
the change in properties of membrane including permittivity and conductivity according to 
the single shell model. As shown in this figure, there should be a substantial change in 
permittivity and conductivity of the cells when treated with Iressa.  
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4.2.4 Discussion 
Before importing the data to the matlab code for further analysis, the values of cell radii and 
the percentage of the both populations were collected into table 2. 
The data were then analysed through the same process as the previous section by the 
programmed code in Matlab. The values of electrophysiological properties of cells membrane 
and cytoplasm were then obtained (Figure 3a-d). In order to follow the same method of 
demonstration, the values of only first population were illustrated in below figures. 
 
Table 4-2 Table of population percentage and the cells radii values of T47D cells 
Trials HC 
(1st pop) 
HC 
2nd pop 
6HR 6HR 
2nd pop 
16HR 16HR 
(2ndpop) 
22HR 22HR 
2nd pop 
Cell radius 6.50E-06 1.00E-06 6.30E-06 1.20E-06 5.50E-06 8.00E-07 5.00E-06 3.00E-
07 
Cell 
population 
percentage% 
65±8 45±6 60±5 40±4 55±7 41±5 35±6 55±6 
 
Irradiation 2nd pop Irradiation+Iressa 2nd pop 
4.50E-06 1.00E-
06 
5.20E-06 3E-07 
40±5 45±7 35±5 50±5 
 
 
With regards to the percentage of the populations collected in the table above, there is a 
considerable percentage belongs to the second population of HC (untreated cells) which is in 
large contradiction with the amount of second population measured in HN5 untreated cells. 
This conflict in sizes between these two cell lines is mainly because of the nature of these 
cells. For instance, as shown in figure 4-6, when HN5 cells become detached from the culture 
flask, they will appear as more well-separated and circular than T47D cells observed in 
packed and non-spherical shapes. Despite this difficulty in measurement, best efforts have 
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been taken to measure the T47D cell radii in the way which HN5 has been carried out. As 
shown in table 4-2, the level of first population starts decreasing as the time of the trials 
approached 22hr of post treatments of Iressa solely and also when combined with irradiation. 
This decrease in the rate of first population is quite similar to what detected in HN5 
treatments defining the reduction of healthy cells within the post treatments of the cells. 
The values of membrane and cytoplasm properties were then obtained from the same Matlab 
code used previously. Similar to the previous section (HN5), the values of only first 
population were put down into the graphs 4-8a-d for presentation.    
 
Figure 4-8 a) the average values of cytoplasm conductivity for all types of treatment 
 
In the graph above, the conductivity of the cytoplasm for the single treatment of Iressa 
remained relatively the same during the post treatment time. Irradiation itself had also no 
influence on the value of conductivity, but when combined with Iressa, the treatment left a 
significant decrease in the value of conductivity from 0.5 S/m down to 0.24 S/m. 
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Figure 4-8 b) cytoplasm relative permittivity values of cells 
 
In figure 4-8 b, the permittivity of cytoplasm started to rise slightly from 6hr of post 
treatment from 58 to 63. There is also a quick increase about 8 units in values of permittivity 
when treated with irradiation, but the most distinctive change can be seen from the 
combination treatment as the value of permittivity reduced from 60 to about 40 units.   
 
Figure 4-8 c) values of cells membrane conductance 
 
 
This figure 4-8 c) shows a substantial drop in value of the membrane conductance about 220 
S when cells were undergone the treatment of both Iressa and Irradiation. Unlike the 
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combination, the other two single treatments did not leave any significant change in values of 
conductance. 
 
 
Figure 4-8 d) cells membrane capacitance values 
 
The values of membrane capacitance in figure 7-d have no distinctive change when cells 
treated solely with Iressa. The Irradiation supressed the value of capacitance slightly to 6.5 
which again like Iressa treatment did not change the values substantially. Unlike the other 
two treatments, combination treatment did rise the capacitance value from 7 up to 9 mf/m2. 
These results may cause confusion that despite the significant change in spectra produced in 
figure 4-7, the values in figure 4-8 demonstrates no substantial alteration in dielectric 
properties of the cells. The reason is that the spectra made by Matlab code was generated 
based on data of the both populations of T47D cells, but the figure 7a-d illustrated only the 
values belong to the first population. In the next section, this case will be discussed through 
comparison of T47D and HN5 cells electrophysiological properties.  
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4.2.5 Conclusion 
In the part of HN5 investigation, HN5 cells were treated with Iressa, cisplatin, irradiation and 
MTX to find out which of these treatments could have the highest impact on the 
electrophysiological properties of the cells. Results met with the previous clinic studies 
proving that combination of drug with another drug and also irradiation can boost the 
influence of drug which was Iressa (ZD1839) in this case. For instance, a more substantial 
change has been observed when Iressa combined with irradiation and Cisplatin compared to 
the maximum post treatment trial which was 22hr. Combination of Iressa with Cisplatin 
appeared to have relatively the highest impact on HN5 cells membrane capacitance by 
decreasing the value from 15 to 8 mf/m2. On the other hand, MTX, cisplatin and irradiation 
solely were not able to leave a significant change on the cells properties as the values of 
membrane and cytoplasm parameters remained relatively the same comparing to untreated 
cells. In fact, the existence of Cisplatin and irradiation helped either Iressa to imply more 
impact on the properties of the cells or irradiation and Cisplatin to reduce the level of cells 
resistance to their single treatments.  
In the second part of this chapter, the effects of different treatments with Iressa and 
irradiation were examined to detect how these treatments could impact the integrity of the 
cells through analysis of dielectric properties of treated cells . Cells were first treated with 
Iressa then irradiation and finally with combination of these two.   
The values gained from single treatment of Iressa showed a slight change in conductivity and 
permittivity of cytoplasm and relatively no distinctive change in values of membrane 
dielectric properties. Radiotherapy also appeared to have a non-significant change in 
cytoplasm properties and roughly no alteration in values of cells membrane capacitance and 
conductance compared to healthy control (untreated cells) values. Similar to the HN5 
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treatment results, T47D seemed to be vulnerable when treated with combination of Iressa and 
irradiation which again proved the vital idea of combination in treatment of cancer cells. In 
contrast with the HN5 cells, values of T47D cells dielectric properties showed less change 
perhaps due to less vulnerability of T47D cells to single treatment of Iressa in the first part of 
this investigation.  
  The reason of significant changes observed in properties of membrane and cytoplasm can be 
explained in either effects of EGFR inhibition from Iressa and irradiation or DNA damage 
from cisplatin and irradiation. The inhibition of EGFR results in blockage of protein 
phosphorylation, arrest of cell mutation cycle in G2 phase and two other further consequence, 
necrosis and apoptosis of the cells.  
1) Phosphorylation of proteins: Ismailov et. al found out that there is a link between 
phosphorylation of proteins ( tyrosine kinase in this case) and polarization of ions 
within the integrity of the cells, thus blockage in process of phosphorylation induces a 
change in polarization of ions and consequently dielectric characteristics of cytoplasm 
and membrane such as permittivity and conductivity(Ismailov, Benos 1995).  
2) The arrest of cell mutation cycle in G2 phase: The arrest of cell cycle in G2 phase 
could impact the capacitance of the cell membrane with respect to the study carried 
out by Huang et. al in 1998. They discovered that variation in membrane lipid 
accumulation as a result of cell cycle arrest leads to alteration of cell membrane 
capacitance from 16mf/m2 to less that 10mf/m2.  
3) The apoptosis and necrosis of the cells; According to the study carried out by 
Gascoyne et. al in 2002 about the effect of GEN (genistein) on HL-60 cells, the value 
of membrane capacitance dropped noticeably from 17.6±0.9 to 9.1±0.5 mF/m2 4 h 
after treatment. The alteration in value of cells membrane capacitance was found to be 
a characteristic of cells which happened to go apoptotic or necrotic. In another 
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research conducted by M Hughes et.al, the cells cytoplasm conductivity and 
membrane capacitance were affected significantly as a result of apoptosis in K562 
cells. The substantial change in electrophysiological properties of cells were mainly 
found to be a result of disruption in flux of ions transmembrane channels. This 
disruption could lead to alteration of cytoplasmic pH and production of ceramide 
which has an important role in apoptosis.  
With respects to the fact of personalized and stratified medicine, the results obtained from 
this investigation proved the high potential of DEP in examination of different cancer 
treatments for different types of cell lines. In other words, DEP appeared to be a helpful asset 
in evaluation of chemo and radio therapies on head and neck and also breast cancer cells. 
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4.3. Comparison of Iressa effects on T47D and HN5  
4.3.1 Introduction 
Currently, there are many chemotherapeutic drugs prescribed both for HN(head and neck) 
and breast carcinoma cancer such as Erlotinib, Gefitinib and Cisplatin. Depending on the 
level of cancer intensity, these drugs are used solely or in combination with other drugs and 
also radiotherapy. Previous studies indicated a synergistic effect on cancer cells when drugs 
like Gefitinib were accompanied by other drug like Cisplatin or irradiation (Chen, Changhu 
2007). As well as type of the drugs, the dosage of prescribed drugs irradiation may also vary 
depending on what other drugs or radio-sensitisers are used in parallel. Some of prescribed 
drugs may not impact the tumour cells as expected in treatment planning due to high level of 
cells’ resistance to drugs or irradiation. Some of drugs may also have some unexpected side 
effects which in some cases have fatal results on patients. Therefore, stratified and 
personalised medicine could help scientists to investigate the effect of specific drugs on 
specific type of cancer cells, group of patients and each patient to reach the most suitable 
treatment. Whilst personalized medicine remains a long-term ideal, the costs and effort 
associated with determining a precise dose for a patient’s genotype and phenotype means that 
for now, it is beyond what can reasonably be offered.  Consequently, there is a need to assess, 
rapidly and at low cost, which interventions a cell is most susceptible to.  In order to see 
whether DEP analysis could meet such a need, cancer cells were treated with a standardized 
dose of pharmaceutical agents at concentrations selected to represent the upper threshold 
dividing resistance and sensitive cells. 
In this study, the effect of Iressa (Gefitinib or ZD1839) on two different types of cells 
representing head and neck and also breast cancer was investigated. Iressa is both prescribed 
for HN and breast cancer, but recent studies revealed that Iressa does not damage the 
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cancerous cells of breast carcinoma cells as desired. HN5 representing head and neck and 
T47D representing breast carcinoma cells were used for this investigation. The main idea of 
this investigation was originally suggested by Dr. H Coley a biologist working on cancer 
cells in University of Surrey. They realised that T47D cells treated by Iressa did exhibit high 
level of resistance compared to HN5 cells. Consequently, DEP was offered as a helpful tool 
to investigate the effect of Iressa on these cell lines.   
As mentioned earlier, Iressa supresses the proliferation of cancer cells through blockage of 
EGF receptors signalling process known as one of the main causes of cancer development. 
HN5 cells were found to have high level of EGFR expression scientifically known as over-
expressed unlike the T47D cells which express very low level of EGFR expression. (Konecny 
et al. 2006). Accordingly, Iressa may not be an appropriate choice for treatment of cells with 
low level of EGFR expression such as T47D. This investigation aims to detect the level of 
alteration which Iressa cause for electrophysiological properties of the cells. These changes 
may be attributed to efficacy of Iressa for treatment of head and neck and breast cancer. 
4.3.2 Method and results 
The data obtained from treatment of T47D and HN5 cells n previous chapters were all 
collected to compare the changes of treated cells against untreated ones (HC). As discussed in 
first chapter, second population is assumed to represent the debris or cells undergone 
apoptotic or necrotic. Therefore, only the values of first population were taken for this 
investigation. The data were then imported to excel for statistical analysis by ANOVA test. 
This test could define whether two sets of values are statistically the same or not.  
The data were analysed by ANOVA test and then collected into tables 4-3 for each of the 
investigated cell lines.  
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Table 4-3. Results of statistical analysis of the cells dielectric properties, showing the p-values derived from an 
ANOVA test of combinations of all tests against each other, for statistically significant differences 
Cytoplasm Differences                                            
HN5 
HC(untreated 
cells) 0hr 6hr 16hr 22hr 
HC(untreated cells)   0.8463 0.00231 1.33E-05 5.23E-14 
0hr 0.934732   0.134 0.00713 5.23E-14 
6hr 0.98818 0.061296   0.00301 3.13E-13 
16hr 1.93E-03 1.00E-01 0.00985   3.89E-02 
22hr 1.36E-12 1.56E-12 0.000602 0.009185   
 
T47D HC 0hr 6hr 16hr 22hr 
HC   0.7654 0.5789 0.3881 0.146 
0hr 0.934732   0.7223 0.6321 0.09441 
6hr 0.824732 0.934732   0.5433 0.09111 
16hr 0.404732 0.934732 0.029289   0.0788 
22hr 0.08991 0.11222 0.06023 0.112519   
 
Membrane differences: 
HN5 HC 0hr 6hr                       16hr          
HC(healthy control)   0.986444 1.30E-11 1.80E-10 1.71E-11 
0hr 0.934732   1.30E-11 1.79E-10 1.68E-11 
6hr 0.0324 0.3221   1.30E-10 1.33E-10 
16hr 1.93E-10 1.80E-10 1.33E-08   1.09E-11 
22hr 1.36E-13 1.93E-10 9.21E-12 0.912519   
 
T47D HC 0hr 6hr 16hr 22hr 
HC   0.9877 0.8901 0.63321 0.098112 
0hr 0.984732   0.09134 0.49901 0.65022 
6hr 0.700732 0.22613   0.70188 0.2995 
16hr 0.334732 0.334111 0.428872   0.080449 
22hr 0.089629 0.100022 0.06023 0.091252   
 
The left column represents cytoplasm differences (permittivity below the black diagonal, conductivity above). 
The right column shows membrane differences (conductance above the diagonal, capacitance below). Where 
statistical significance is demonstrated, the result is highlighted in red orange. 
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4.3.3 Discussion and conclusion 
In this section, the electrophysiological values gained in previous parts for both cell lines 
were analysed and compared to evaluate the effect of Iressa treatment. Iressa is known to 
target the cancer cells through inhibition of EGF receptors, so any cell line which has high 
level of EGFR expression should resist less against the treatment of Iressa. HN5 cells were 
found to have much more EGFR expression compared to T47D in clinical studies, so Iressa 
theoretically is expected to have more effect on HN5 than T47D.  
The properties of the cells including membrane and cytoplasm were compared by ANOVA 
statistical test to detect the significant changes caused by Iressa. Based on p-values in table 4-
3, both conductivity and permittivity values of HN5 cells cytoplasm were significantly 
different from 6hr to the end of treatment which was 22hr (p values<0.001). In contrast, the 
values of T47D cytoplasmic properties had no significant change. Same outcome was gained 
for capacitance and conductance values of both cell lines.  
In the research conducted by Chen et al in 2007, the growth inhibition rate significantly 
increased when Iressa was used in combination. Their study demonstrated that if EGFR 
inhibitors like Iressa accompanied by cisplatin, there would be a synergestic effect expected 
as outcome. Unlike additive effect which is the sum of two different treatments, synergistic 
effect represents much more significant result. In this study, Cisplatin appeared to have way 
more significant change (p values in dielectric properties) than additive result when used in 
combination with Iresssa.  
In the research conducted by Chen et. al in 2007, combination of Iressa (ZD1839) with other 
chemotherapeutic drugs like Cisplatin showed a synergistic effect due to increase in 
cytotoxicity of the agents (Chen et al 2007). With respect to this study, DEP was able to 
detect the synergistic effect of Iressa on HN5 cells rather than additive. In fact, the sum of 
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changes in values of dielectric (especially cytoplasm) properties for solo treatments of HN5 
was substantially lower than the values when combination treatments were involved. 
Therefore, this significant difference in results can rule out the additive effect over synergistic 
effect of Iressa. 
 Cells exhibited no statistically signiﬁcant changes in dielectric properties fol-lowing 
radiation exposure alone. However, when performed in the presence of Iressa, there was a 
marked change observed after exposure, with HN5 dropping in cytoplasm conductivity by 
52%. Similar changes were observed in membrane properties, with HN5 exhibiting a 
reduction of 44% in membrane capacitance Statistical analysis indicated no signiﬁcant 
change after radiation in any parameter when compared to control, but showed signiﬁcant 
changes against control in all parameters when irradiation was accompanied by Iressa (p 
<0.1%).  
DEP was aable to assess how drug action could be increased through combinations with other 
pharmaceutical interventions and radiotherapy, which showed an enhanced effect when 
compared to these interventions alone.  This suggests that a DEP-based assay could 
potentially be used in a standard pathology laboratory setting, where biopsy cells can be 
screened at low cost and high speed, enabling the selection of an appropriate course of 
treatment from the outset, increasing patient survival rates whilst reducing time and cost for 
the health provider. 
Whilst conventional methods of cell electrophysiological analysis such as patch-clamp and 
ﬂow cytometry are expensive and time-consuming, dielectrophoresis (DEP) appeared to be 
an effective method of assessing cell population state after drug action. However, DEP 
analysis does have a few drawbacks like lack of accuracy in investigation of drugs with 
concentration less than 5micromol or the cells with less circular shapes when detached from 
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culture flasks. The analysis program is also not quite user-friendly, but some trials are 
conducted to improve the function of DEP-tech program. 
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General conclusion and key achievements 
This project mainly aimed to investigate the effects of different treatments on dielectric 
properties of HN5 and T47D cell lines through DEP analysis. It was also planned to correlate 
any substantial changes in values of cells permittivity and conductivity parameters caused by 
treatments with other biological phenomenon such as EGFR expression. As it was necessary 
to ascertain detached cells (HN5 and T47D) would remain steady in terms of their dielectric 
properties, all common detachment methods were examined by DEP analysis and other 
viability tests. The key achievements of this project can be discussed in three parts: 
1- Application of DEP in investigation of cell detachment methods 
There has always been a doubt about the effect of chemical and physical detachment methods 
on structure of cells. Therefore, some common chemical detachment substances and 
harvesting method were examined to determine whether electrophysiological properties of 
adherent cells remain intact or alter after detachment procedure. Trypsin-EDTA, Dissociation 
Fluid, Dissociation Buffer and Accutase were the chemical substances used in this 
investigation as well as a reagent-free harvesting (scraping) method. Prior to the study of 
adherent cells (HN5 and T47D), the values of suspension cells (K562) dielectric properties 
were analysed when treated with same chemical substances.  
The values of dielectric properties of HN5 cells exhibit a substantial change when cells 
detached by scraping method. In both HN5 and T47D a distinctive decrease was observed in 
values of cells membrane conductance and capacitance meaning that scraping could 
potentially affect the integrity of adherent cells particularly membrane. The values of 
dielectric parameters obtained from suspension cells (K562) did not indicate any significant 
change which proved the consistency of cells properties before and after applying chemical 
reagents. However these significant changes may indicate that scraping disrupt or affect the 
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function of cells, there cannot be an absolute certainty about these values due to variation in 
size and population of detached cells. 
In this project, DEP technique demonstrated the fact that mechanical methods may not be an 
ideal way to detach the adherent cells compared to chemical reagents commonly used in 
biological studies. It has been also observed that most common chemical substances except 
Gibco keep the cells dielectric properties intact meaning that there is no significant difference 
between enzymatic substances such as Trypsin and non-enzymatic ones like Accutase in 
terms of their effect on adherent cells.  
2- Capability of DEP in evaluation different cancer treatment 
Investigation of cancer treatments effects on a particular cancer cell line is a key asset in 
definition of personalized and stratified medicine.  In this study, three chemotherapeutic 
drugs including Iressa, Cisplatin and MTX with different functions were examined solely and 
also in combination with irradiation. The cells were treated by each chemotherapeutic drug 
and afterwards examined by DEP up to 22 hours of incubation time. In treatment of HN5 
cells, Iressa reduced the values of cytoplasmic conductivity from 0.5 to 0.2 S/m and 
substantially increase the cytoplasmic relative permittivity from 55 up to 100 when incubated 
for 22hr and also combined with irradiation and half dosage with Cisplatin. There was also a 
significant drop in values of membrane capacitance from 16 to 8 F/m2. On the other hand, 
single treatment of Cisplatin, MTX and irradiation appeared to cause no significant change in 
values of dielectric parameters indicating a high resistance level of HN5 to these treatments.    
T47D cells were treated with Iressa, irradiation and combination of both and examined by 
DEP throughout the same procedure and incubation times done for HN5 cells. Similar to 
HN5 results, irradiation was found to intensify the change in values of both membrane and 
cytoplasm parameters when mixed with Iressa treatment. In cells membrane parameters, there 
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was a significant drop detected in values of conductance from 360 down to 150 S/m2. 
Conductivity of cytoplasm also experienced a significant fall from 0.5 down to 0.2 S/m.  
The changes in values of dielectric properties obtained from treatments of these cell lines 
may be correlated to three types of biological phenomenon caused by treatment of Iressa. The 
first one is phosphorylation of proteins which alters the level of ions polarization resulting to 
change in properties of cancer cells including membrane and permittivity. Arrest of cell cycle 
in G2 phase is another further effect of Iressa which could influence the property of 
membrane capacitance. The last phenomenon is apoptosis known as another further 
consequence of Iressa treatment which could affect the membrane dielectric parameters 
specifically capacitance.  
Despite the uncertainties mainly caused by variation in size and population of treated cells, 
DEP successfully proved its capability as a useful technique in evaluation of different cancer 
treatments through analysis of cells electrophysiological properties.   
3- The role of DEP in “personalized” and “stratified” medicine  
Personalized and stratified medicine define the study of specific type of treatment effects on 
particular type of cell line. Iressa(ZD 1839) is one of the most common drugs prescribed for 
various types of cancers including head and neck and breast carcinoma. This 
chemotherapeutic drug targets the cancer cells by blockage of EGF signaling process 
happened in cancerous cells. It has been found that Iressa has higher effect when used for cell 
line with high level of overexpression such as HN5 unlike T47D carcinoma cells. In this part 
of this research, the values gained in previous part were analysed and statistically compared 
by ANOVA test to determine which cell line respond better to treatment of Iressa.  
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The statistical values indicated significant changes in dielectric parameters during the post-
treatment of Iressa compared to untreated cells. In contrast, no significant change has been 
detected from the treatment of T47D cells with Iressa. This contradiction in statistical results 
proves the high level of T47D cells resistant against the treatment of Iressa. Whilst 
personalized medicine remains a long-term ideal, the costs and effort associated with 
determining a precise dose for a patient’s genotype and phenotype means that for now, it is 
beyond what can reasonably be offered.  Consequently, there is a need to assess, rapidly and 
at low cost, which interventions a cell is most susceptible to.  In order to see whether DEP 
analysis could meet such a need, cancer cells were treated with a standardized dose of 
pharmaceutical agents at concentrations selected to represent the upper threshold dividing 
resistance and sensitive cells.  Within 6h, it was possible to discriminate between those 
affected by the drug from those that were not, by observing changes in the membrane 
capacitance and cytoplasm conductivity.  It was also able to assess how drug action could be 
increased through combinations with other pharmaceutical interventions and radiotherapy, 
which showed an enhanced effect when compared to these interventions alone.  This suggests 
that a DEP-based assay could potentially be used in a standard pathology laboratory setting, 
where biopsy cells can be screened at low cost and high speed, enabling the selection of an 
appropriate course of treatment from the outset, increasing patient survival rates whilst 
reducing time and cost for the health provider. 
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Future prospects 
The results in this project were obtained through in-vitro experiments performed on cell lines 
grown up in biological laboratory. In order to take DEP into real concept of personalized or 
stratified medicine, more experiments must be taken specifically with clinical samples. 
Ethical issues known to be the main obstacle in gaining clinical samples from medical 
centers. Furthermore, DEP technique needs to gain more trust from medical experts to be 
involved in any type of clinical studies.  
There are a few factors about DEP experiments need to be improved for further 
investigations. DEP medium in this project was prepared manually for the experiments which 
could expose the substance to surrounding microorganisms, despite all cares taken during the 
preparation. Fortunately, Prof. M Hughes and his colleagues have recently started working on 
DEP medium prepared and packaged in more sterile environment offered by a biological 
supplier.  As DEP analysis highly depends on cells radii, the measurements should be carried 
out decently by more sophisticated devices. There has been a device made for such purpose, 
but definitely it needs more technical improvements. The software used for DEP analysis 
should become more user friendly and less complicated especially for commercial purposes.    
 
 
          
 
